Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3010726	s-hevohie	— (—)	4206	4363	100.00%	Distribution not available
3010726	s-hevohie	kU/l (u/ml)	2926	3154	3.36%
3010726	s-hevonee	kU/l (u/ml)	1655	1731	0.00%
3010726	hevonen	— (—)	613	645	100.00%	Distribution not available
3010726	hevonee	kU/l (u/ml)	174	186	0.00%
3010726	s-hevosenhilse,igevasta-aineet	kU/l (u/ml)	148	151	0.00%
3010726	s-hevonhie	kU/l (u/ml)	127	128	0.00%
3010726	igehevonen	kU/l (u/ml)	122	128	0.00%
3010726	hevonen	kU/l (u/ml)	81	82	0.00%
3010726	s-hevohie	kU/l______ (u/ml)	59	59	0.00%
3010726	s-hevonee	kU/l______ (u/ml)	49	49	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma, unspecified (mode)

1388

2395

4.31

307.65

1.1

1.0

1.41

1.53

u/ml

0.19

747

888

Asthma (diagnoses ohter than nonallergic)

3231

6273

4.35

307.65

1.2

1.1

2.53

1.56

u/ml

4.98

2133

2785

Suggestive for eosinophilic asthma

368

367

10.94

307.65

1.3

1.0

1.17

1.18

u/ml

0.01

277

155

Asthma, hospital admissions , main diagnosis only

3119

6442

4.42

307.65

1.2

1.1

2.53

1.54

u/ml

5.06

2029

2909

Obesity related asthma

957

2191

4.55

307.65

1.1

1.0

2.17

1.13

u/ml

2.53

572

919

Allergic asthma (mode), excluding more controls

1558

1799

9.39

307.65

1.2

1.0

3.13

2.00

u/ml

2.16

1189

705

Asthma (mode)

2899

2678

5.97

307.65

1.1

1.0

2.38

1.66

u/ml

1.86

1838

1005

Asthma-related infections

1996

4687

4.34

307.65

1.2

1.1

2.57

1.44

u/ml

4.87

1338

2120

Chronic lower respiratory diseases

3894

5559

3.82

307.65

1.1

2.50

1.41

u/ml

6.68

2374

2457

Asthma and allergy

1156

1116

11.95

307.65

1.2

1.0

3.42

1.61

u/ml

5.09

896

456

Chronic sinusitis

1185

2876

4.28

307.65

1.2

1.0

0.85

1.92

u/ml

5.34

673

1196

Conjunctivitis

2455

6778

3.02

307.65

1.1

2.41

1.86

u/ml

1.67

1500

3291

Nasal polyp

544

828

6.92

307.65

1.2

1.0

1.08

1.36

u/ml

0.44

379

357

Asthma, unspecified (mode), excluding more controls

1382

2374

4.30

307.65

1.1

1.0

1.41

1.55

u/ml

0.20

743

876

Allergic conjunctivitis

2140

6120

3.52

307.65

1.1

2.42

1.77

u/ml

2.10

1331

2906

Asthma and allergy, excluding more controls

1156

1142

11.68

307.65

1.2

1.0

3.41

1.58

u/ml

5.30

897

465

1738

3966

4.58

307.65

1.2

1.1

2.71

1.51

u/ml

4.42

1168

1827

Asthma (only as main-diagnosis), excluding more controls

2856

2642

6.31

307.65

1.2

1.0

2.32

1.68

u/ml

1.51

1814

986

Vasomotor and allergic rhinitis

2471

3454

7.75

307.65

1.2

1.0

2.68

2.25

u/ml

0.80

1681

1516

Asthma, including avohilmo

4234

5093

4.78

307.65

1.1

2.48

1.28

u/ml

8.27

2510

2263

Allergic rhinitis

2371

3457

7.70

307.65

1.2

1.1

2.70

1.68

u/ml

4.16

1647

1572

Dermatitis and eczema

2609

6529

2.41

307.65

1.1

2.62

1.40

u/ml

6.81

1569

3040

Chronic rhinitis, nasopharyngitis and pharyngitis

1008

2262

4.66

307.65

1.1

1.0

1.09

1.84

u/ml

2.15

595

978

Asthma

2881

2668

5.84

307.65

1.1

1.0

2.35

1.66

u/ml

1.72

1821

1000

Asthma, excluding more controls

2852

2642

5.82

307.65

1.1

1.0

2.38

1.68

u/ml

1.70

1800

986

Disorders of conjunctiva

2500

6942

2.88

307.65

1.1

2.40

1.84

u/ml

1.79

1521

3366

Pollen allergy

1902

2487

9.10

307.65

1.2

1.1

2.75

1.88

u/ml

2.41

1341

1197

Asthma/COPD (KELA code 203)

3165

5540

3.96

307.65

1.1

2.67

1.42

u/ml

7.81

1972

2452

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2072

5774

3.60

307.65

1.1

2.33

1.73

u/ml

1.90

1284

2728

Other diseases of upper respiratory tract

2424

4351

2.97

307.65

1.1

1.0

1.91

1.98

u/ml

0.11

1434

1881

Asthma, hospital admission 2, infections

1996

4687

4.34

307.65

1.2

1.1

2.57

1.44

u/ml

4.87

1338

2120

Asthma (only as main-diagnosis)

2868

2668

6.33

307.65

1.2

1.0

2.31

1.66

u/ml

1.58

1820

1000

Desensitization to allergens

577

817

8.92

307.65

1.2

1.1

2.23

2.04

u/ml

0.18

434

428

Allergic asthma (mode)

1559

1792

9.43

307.65

1.2

1.0

3.13

2.00

u/ml

2.17

1189

705

Atopic dermatitis, strict definition with reimbursement

1396

3907

3.65

307.65

1.2

1.1

3.91

1.73

u/ml

8.82

1016

1885

Atopic dermatitis

2160

5812

3.08

307.65

1.1

3.17

1.52

u/ml

8.76

1367

2700

Atopic dermatitis, strict definition

1321

4340

3.15

299.35

1.2

1.1

4.07

1.94

u/ml

7.95

970

2178

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1117

3320

3.33

286.64

1.1

1.0

1.40

1.87

u/ml

0.98

611

1384

Other pulmonary diagnosis

1597

2713

3.01

286.21

1.1

1.0

1.79

1.72

u/ml

0.08

902

1022

COPD differential diagnosis

1570

2678

3.00

279.50

1.1

1.0

1.70

1.66

u/ml

0.05

888

1005

ILD differential diagnosis

1568

2678

2.99

278.52

1.1

1.0

1.70

1.66

u/ml

0.05

887

1005

Excluding asthma or asthma-COPD overlap

1574

2713

2.96

275.36

1.1

1.0

1.71

1.72

u/ml

0.02

888

1022

Childhood asthma (age<16)

709

1233

4.83

273.83

1.2

1.0

3.94

2.19

u/ml

2.71

523

510

Childhood asthma (age<16), excluding more controls

708

1235

4.81

272.40

1.2

1.0

3.95

2.19

u/ml

2.72

522

510

Asthma-related pneumonia or sepsis

782

2009

3.99

265.58

1.2

1.1

2.17

1.49

u/ml

1.22

528

915

Asthma, hospital admissions 3, pneumonia

782

2009

3.99

265.58

1.2

1.1

2.17

1.49

u/ml

1.22

528

915

Asthma-related pneumonia

779

1998

4.00

265.19

1.2

1.1

2.17

1.49

u/ml

1.20

526

906

Oral corticosteroids

2345

6132

2.28

258.98

1.1

2.09

1.73

u/ml

0.99

1395

2865

Undetermined asthma

382

591

6.78

236.25

1.2

1.0

1.19

1.15

u/ml

0.04

229

226

Undetermined asthma, excluding more controls

382

595

6.74

234.71

1.2

1.0

1.19

1.14

u/ml

0.04

229

ILD medications: prednisolone, methylprednisolone, prednisone

2397

6247

2.17

231.53

1.1

2.16

1.77

u/ml

1.12

1427

2990

Cough

1008

3100

3.12

230.11

1.1

1.53

2.18

u/ml

0.99

585

1538

Diseases of the respiratory system

1172

2022

2.96

204.87

1.1

1.0

1.76

1.52

u/ml

0.32

638

777

Abnormalities of breathing

2056

5584

2.14

194.27

1.1

1.87

2.08

u/ml

0.41

1155

2709

Biological medicines for asthma

206

202

12.96

192.14

1.3

1.1

3.57

1.41

u/ml

1.63

155

103

ILD medications

2405

6596

2.00

185.86

1.1

2.13

1.87

u/ml

0.61

1422

3203

Childhood allergy (age < 16)

859

2424

3.15

183.24

1.2

1.1

3.75

2.41

u/ml

2.57

659

1243

Inflammatory bowel disease treatment related agents

2389

6805

1.98

181.29

1.1

2.07

1.84

u/ml

0.53

1411

3297

Deviated nasal septum

579

1641

3.61

171.07

1.1

1.0

1.36

1.66

u/ml

0.36

321

670

FESS (DNB20)

419

998

4.45

160.74

1.2

1.1

0.71

1.49

u/ml

2.78

253

475

First line medication for Crohn's disease

2297

6532

1.92

159.12

1.1

2.11

1.86

u/ml

0.58

1358

3162

Ethmoidectomy

423

1031

4.34

157.33

1.2

1.1

0.71

1.46

u/ml

2.73

255

493

Adverse effects, not elsewhere classified

680

2269

3.15

156.55

1.2

1.1

2.94

1.81

u/ml

1.90

474

1183

Symptoms and signs involving the circulatory and respiratory systems

2140

5609

1.94

150.23

1.1

1.70

2.08

u/ml

1.09

1194

2716

Conjunctivitis (acute, non atopic), including avohilmo

1868

5724

2.00

149.67

1.1

2.02

1.73

u/ml

0.63

1013

2730

Chronic diseases of tonsils and adenoids

1442

4273

2.16

143.38

1.1

1.0

1.77

2.02

u/ml

0.44

781

1839

Dermatitis due to ingested food

310

665

5.28

131.49

1.3

1.1

5.17

2.37

u/ml

2.70

257

394

Other and unspecified effects of external causes

795

3366

2.44

113.73

1.2

1.1

2.81

1.97

u/ml

1.36

533

1759

Urticaria

816

3556

2.36

109.11

1.1

2.02

1.97

u/ml

0.05

516

1842

Non-allergic asthma (mode)

335

902

3.77

105.60

1.1

1.0

0.88

1.61

u/ml

1.33

164

369

Non-allergic asthma (mode), excluding more controls

335

904

3.76

105.26

1.1

1.0

0.88

1.61

u/ml

1.33

164

371

Urticaria and erythema

898

4152

2.22

103.74

1.1

2.13

1.95

u/ml

0.23

565

2165

Acute upper respiratory infections of multiple and unspecified sites

1523

6177

1.82

96.90

1.1

2.21

1.90

u/ml

0.52

848

3032

Acute upper respiratory infections

1817

6347

1.73

94.19

1.1

1.88

1.86

u/ml

0.04

985

3128

Asthma mixed form (mode)

145

215

7.10

93.79

1.2

1.0

2.31

1.26

u/ml

0.62

Asthma mixed form (mode), excluding more controls

145

215

7.10

93.77

1.2

1.0

2.31

1.25

u/ml

0.64

Dyspnoea

1535

6229

1.80

93.72

1.1

1.57

1.87

u/ml

0.76

883

3075

Acute sinusitis

1154

5529

1.93

90.93

1.1

1.57

1.82

u/ml

0.46

620

2690

Diseases of the eye and adnexa

1732

5011

1.76

89.40

1.1

2.14

2.05

u/ml

0.13

988

2446

Insomnia

1708

7035

1.71

86.59

1.1

1.84

1.81

u/ml

0.04

818

3560

Diseases of the skin and subcutaneous tissue

1703

4951

1.74

86.52

1.1

2.13

1.46

u/ml

2.20

994

2232

Bronchitis

1953

7131

1.66

86.27

1.1

2.07

1.76

u/ml

0.69

1082

3512

Any reimbursement code in KELA

1455

4044

1.83

86.23

1.1

2.39

1.49

u/ml

2.97

855

1798

D07AA Corticosteroids, weak (group I)

514

2034

2.63

85.53

1.2

1.1

5.23

1.98

u/ml

6.36

386

1111

Sleep disorders

1698

6993

1.69

82.76

1.1

1.84

1.85

u/ml

0.01

827

3552

Other medical care

703

2735

2.19

77.41

1.2

1.1

2.33

1.68

u/ml

1.16

494

1363

Polypectomy (DHB20)

166

338

5.16

77.31

1.3

1.1

0.57

1.56

u/ml

2.16

124

162

Personal history of allergy to drugs, medicaments and biological substances

101

10.61

74.17

1.5

1.1

0.68

1.13

u/ml

0.43

Behavioural syndromes associated with physiological disturbances and physical factors

1728

7221

1.64

74.10

1.1

1.98

1.93

u/ml

0.07

853

3729

1846

5787

1.63

73.82

1.1

1.95

1.75

u/ml

0.36

997

2785

Sleep apnoea, including avohilmo

1580

5753

1.68

72.97

1.1

1.57

u/ml

0.00

778

2832

Dermatitis

964

5097

1.87

70.84

1.1

2.01

1.30

u/ml

1.35

560

2331

Other acute lower respiratory infections

983

5110

1.86

69.95

1.2

1.1

2.62

1.93

u/ml

1.24

602

2691

Early onset COPD, excluding more controls

215

573

3.81

69.75

1.1

1.0

1.84

1.01

u/ml

1.40

133

197

Chronic laryngitis and laryngotracheitis

215

590

3.73

67.25

1.1

1.0

0.94

1.24

u/ml

0.37

245

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1755

7230

1.57

63.19

1.1

1.74

1.99

u/ml

0.55

916

3688

Migraine

1181

5429

1.72

62.24

1.1

1.47

2.14

u/ml

1.97

592

2777

Pain in joint

1078

3761

1.78

61.95

1.1

1.31

2.04

u/ml

2.44

598

1928

Asthma and opportunity respiratory infection

104

8.21

60.80

1.2

1.0

0.71

0.87

u/ml

0.12

Sleep disorders (combined)

1812

6142

1.55

59.80

1.1

1.81

1.94

u/ml

0.22

908

3176

Voice disturbances

444

1949

2.32

58.31

1.2

1.1

1.11

1.30

u/ml

0.33

244

953

Other and unspecified dermatitis

790

4289

1.86

57.70

1.1

1.87

1.32

u/ml

0.86

462

1983

Dentofacial anomalies [including malocclusion]

1420

7085

1.59

55.11

1.1

1.62

2.05

u/ml

1.11

737

3560

Bronchiectasis

154

6.25

55.00

1.1

0.65

1.16

u/ml

0.42

Allergic contact dermatitis

301

1166

2.66

52.36

1.1

1.73

1.01

u/ml

1.29

193

531

Sleep apnoea

1357

5463

1.58

50.05

1.1

1.43

1.52

u/ml

0.13

677

2668

Other and unspecified urticaria

462

2203

2.15

49.87

1.2

1.1

2.04

1.87

u/ml

0.14

287

1138

Acute bronchitis

658

3477

1.88

49.26

1.1

2.25

1.77

u/ml

0.67

380

1808

Dermatographic urticaria

202

673

3.15

47.13

1.2

1.1

1.49

1.53

u/ml

0.03

123

327

Recurrent or chronic depression

754

2927

1.81

47.02

1.1

2.09

1.70

u/ml

0.57

400

1417

Symptoms and signs involving speech and voice

482

2381

2.05

46.87

1.1

1.16

1.25

u/ml

0.14

261

1173

Headache

1265

6302

1.57

46.70

1.1

1.72

2.05

u/ml

0.55

667

3159

COPD/asthma related infections

1634

5495

1.50

45.83

1.1

1.90

1.76

u/ml

0.25

885

2659

COPD/asthma/ILD related infections

1634

5495

1.50

45.83

1.1

1.90

1.76

u/ml

0.25

885

2659

Medical observation and evaluation for suspected diseases and conditions

1073

3368

1.64

44.61

1.1

1.35

2.00

u/ml

2.25

668

1508

Exposure to unspecified factor

1713

8063

1.46

43.82

1.1

1.74

2.02

u/ml

0.65

948

4091

Any death

101

2616

0.27

43.22

1.0

1.1

0.82

1.17

u/ml

0.50

1337

Idiopathic urticaria

100

226

4.84

41.89

1.1

1.20

2.46

u/ml

0.96

121

Triptan medication for migraine, single purchase ok

1446

6636

1.49

41.48

1.1

1.73

2.04

u/ml

0.66

715

3379

Migraine, single triptan purchase ok & required. ICD-code if available is included

1446

6636

1.49

41.48

1.1

1.73

2.04

u/ml

0.66

715

3379

COPD

290

979

2.42

41.06

1.1

1.0

1.46

0.76

u/ml

1.65

174

423

Other chronic obstructive pulmonary disease

274

916

2.46

40.36

1.1

1.0

1.51

0.74

u/ml

1.79

166

394

Special screening examination for infectious and parasitic diseases

620

2512

1.83

40.35

1.1

1.44

2.04

u/ml

0.96

343

1071

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

724

2061

1.78

40.09

1.1

1.85

2.31

u/ml

0.74

376

1014

Intestinal infectious diseases, including avohilmo, including avohilmo

1800

7076

1.43

39.86

1.1

1.73

1.99

u/ml

0.58

927

3613

Other inflammation of eyelid, including avohilmo

903

5655

1.62

39.67

1.1

2.22

1.92

u/ml

0.42

466

2874

Episodal and paroxysmal disorders

1844

6626

1.42

39.35

1.1

1.88

2.07

u/ml

0.33

955

3443

Abnormalities of heart beat

504

2654

1.86

36.87

1.1

1.44

1.79

u/ml

0.49

262

1290

Neurotic, stress-related and somatoform disorders

1537

7435

1.43

36.61

1.1

1.82

1.97

u/ml

0.27

888

3631

Other special examinations and investigations of persons without complaint or reported diagnosis

1039

3368

1.58

36.55

1.1

1.84

2.00

u/ml

0.23

597

1508

Anxiety disorders

1541

7434

1.43

36.40

1.1

1.83

1.97

u/ml

0.26

888

3632

Pain in throat and chest

1317

5298

1.48

36.20

1.1

1.73

2.07

u/ml

0.73

677

2542

Irritable bowel syndrome

498

2754

1.84

34.78

1.1

1.67

1.57

u/ml

0.08

247

1371

Atopic conjunctivitis

140

452

3.26

34.68

1.2

1.1

4.09

1.55

u/ml

1.39

253

All anxiety disorders

1270

6785

1.47

34.53

1.1

1.80

2.08

u/ml

0.56

760

3316

Gastro-oesophageal reflux disease

956

5300

1.53

32.92

1.1

1.04

1.74

u/ml

2.87

462

2637

Coxibs

415

1103

2.00

32.85

1.1

2.78

2.36

u/ml

0.32

196

619

Eosinophilic disease (BM)

9.08

32.60

1.3

1.0

1.73

0.37

u/ml

0.48

Anxiety (asthma-related co-morbidities)

1221

6430

1.46

32.06

1.1

1.81

2.03

u/ml

0.41

729

3107

Temporomandibular joint disorders, including avohilmo

938

6027

1.53

31.89

1.1

1.66

2.11

u/ml

1.02

506

3004

Triptan medication for migraine, min. 3 purchases

1183

6149

1.45

30.47

1.1

1.41

2.00

u/ml

1.84

563

3084

Pain (limb, back, neck, head abdominally)

1139

3888

1.48

30.04

1.1

1.88

2.05

u/ml

0.26

615

2024

Mycoses, including avohilmo

1466

8083

1.39

29.78

1.1

1.72

1.97

u/ml

0.49

727

4136

Examination and observation for other reasons

908

3356

1.54

29.65

1.1

1.33

2.00

u/ml

2.05

532

1504

Exposure to other specified factors

1350

8330

1.40

29.28

1.1

2.31

1.90

u/ml

0.68

744

4245

Depression or dysthymia

910

3263

1.53

29.17

1.1

1.93

1.70

u/ml

0.35

502

1624

Persons encountering health services for examination and investigation

998

3368

1.50

28.04

1.1

1.50

2.00

u/ml

1.33

566

1508

Caries of enamel

1528

7357

1.37

27.49

1.1

1.74

1.92

u/ml

0.33

825

3673

Acetic acid derivatives and related substances

379

1027

1.93

27.23

1.1

2.15

2.08

u/ml

0.04

185

570

Other disorders of lacrimal gland

491

2902

1.71

27.22

1.1

1.97

1.42

u/ml

0.64

235

1421

Conjunctivitis (acute, non atopic)

491

2894

1.71

27.15

1.1

2.73

1.88

u/ml

1.05

287

1476

Pain and other conditions associated with female genital organs and menstrual cycle

495

2455

1.72

26.58

1.1

1.29

2.42

u/ml

2.47

243

1297

Disorders of lacrimal system

581

3559

1.62

26.16

1.1

1.85

1.63

u/ml

0.24

280

1759

Anxiety disorders, excluding more controls

1328

6177

1.38

25.54

1.1

1.77

1.87

u/ml

0.14

772

2964

Other anxiety disorders

982

5832

1.45

25.43

1.1

1.70

2.17

u/ml

1.07

602

2861

Abnormal findings on diagnostic imaging of lung

399

2147

1.77

25.15

1.1

0.91

1.10

u/ml

0.31

214

1070

Bronchitis, not specified as acute or chronic

115

398

2.94

24.98

1.1

1.0

1.52

1.25

u/ml

0.24

167

Other specific joint derangements/joint disorders

1354

6183

1.37

24.98

1.1

1.55

2.22

u/ml

2.09

727

3173

Tonsillectomy and adenotomy

1283

6514

1.38

24.97

1.1

2.35

2.12

u/ml

0.33

698

3381

Other headache syndromes

657

4249

1.56

24.89

1.1

1.90

1.74

u/ml

0.13

346

2072

Codeine

1476

5918

1.36

24.43

1.1

1.09

1.85

u/ml

4.93

754

2898

Diabetes, insulin treatment (Kela reimbursement)

740

6532

0.67

24.23

1.1

1.18

1.71

u/ml

1.60

375

3281

Soft tissue disorders

1694

6589

1.32

23.70

1.1

2.06

2.07

u/ml

0.02

907

3418

Opioids

1580

6137

1.34

23.68

1.1

1.53

2.00

u/ml

1.33

816

3034

Depression

1493

7512

1.34

23.36

1.1

1.79

1.96

u/ml

0.34

852

3674

Codeine or tramadol medication

1646

6791

1.32

23.23

1.1

1.09

1.83

u/ml

5.25

830

3321

Malignant neoplasm

639

5665

0.66

23.21

1.1

1.32

1.54

u/ml

0.40

322

2781

Other dorsopathies, not elsewhere classified

1612

6338

1.33

23.15

1.1

1.66

2.13

u/ml

1.21

879

3176

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

720

6304

0.67

23.01

1.1

1.19

1.75

u/ml

1.67

368

3153

Candidiasis, including avohilmo

502

3123

1.63

22.98

1.1

1.56

1.74

u/ml

0.21

253

1606

Diseases of the musculoskeletal system and connective tissue

1100

3936

1.41

22.94

1.1

2.57

2.40

u/ml

0.18

601

2079

Symptoms and signs involving the digestive system and abdomen

1508

5685

1.34

22.46

1.1

1.72

2.15

u/ml

1.03

786

2962

Acute bronchiolitis

245

1130

2.05

22.37

1.3

1.1

5.13

2.53

u/ml

1.88

188

720

Other soft tissue disorders, not elsewhere classified

1505

6466

1.33

22.36

1.1

2.16

2.06

u/ml

0.13

785

3347

Abdominal and pelvic pain

1503

5684

1.33

22.23

1.1

1.74

2.15

u/ml

0.96

786

2961

Malignant neoplasm

645

5653

0.66

22.15

1.1

1.31

1.54

u/ml

0.43

325

2773

Dorsalgia

1563

6287

1.32

22.11

1.1

1.42

2.10

u/ml

2.52

846

3143

Diseases of middle ear and mastoid

1093

6498

1.38

22.09

1.1

1.59

2.18

u/ml

1.56

606

3360

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1409

8283

1.33

22.08

1.1

2.29

1.90

u/ml

0.69

720

4278

Myalgia

401

2383

1.70

22.01

1.1

2.67

1.69

u/ml

0.72

209

1180

Migraine with aura

527

3367

1.59

21.64

1.1

1.53

2.08

u/ml

0.76

277

1701

Solid cancers

606

5352

0.66

21.55

1.1

1.30

1.45

u/ml

0.24

303

2599

Persons encountering health services for specific procedures and health care

1706

7790

1.30

21.43

1.1

1.78

2.06

u/ml

0.61

1062

3840

Low back pain

1199

5984

1.36

21.23

1.1

1.27

1.99

u/ml

2.55

625

2957

Other antidepressants

1440

5542

1.33

21.22

1.1

1.92

1.94

u/ml

0.02

758

2709

Hyperkinetic disorders, excluding more controls

438

2518

1.66

21.08

1.1

2.48

2.69

u/ml

0.14

270

1344

Allergic urticaria

188

892

2.17

21.01

1.2

1.1

2.70

1.70

u/ml

0.74

119

468

COPD (mode)

156

519

2.36

20.97

1.1

1.0

1.13

0.85

u/ml

0.38

202

Renal tubulo-interstitial diseases

653

7029

0.68

20.87

1.1

1.46

1.93

u/ml

1.10

359

3571

Diabetes medication

934

7537

0.72

20.47

1.1

1.29

1.81

u/ml

1.81

496

3776

Malignant neoplasm, wide definition

701

5906

0.69

20.23

1.1

1.30

1.63

u/ml

0.74

355

2922

Parasetamol

1262

4773

1.34

19.69

1.1

2.44

2.18

u/ml

0.32

668

2411

Migraine with aura and triptan purchases

376

2272

1.69

19.63

1.1

1.74

1.71

u/ml

0.02

205

1173

Neurological diseases

1475

5669

1.31

19.60

1.1

1.97

2.20

u/ml

0.35

765

2976

Other chronic obstructive pulmonary disease, including avohilmo

395

1959

1.66

19.59

1.1

1.33

1.03

u/ml

0.63

242

967

Other joint disorders

1572

6336

1.30

19.59

1.1

1.66

2.23

u/ml

1.81

821

3258

Malignant neoplasm, including Hilmo

708

5920

0.69

19.55

1.1

1.30

1.62

u/ml

0.74

360

2926

Selective serotonin reuptake inhibitors

1431

5677

1.32

19.51

1.1

1.58

2.02

u/ml

1.25

756

2820

All kidney diseases

883

8150

0.72

19.36

1.1

1.65

1.96

u/ml

0.58

490

4132

Eosinophilia

5.16

19.25

1.3

1.1

1.73

1.82

u/ml

0.02

Solid cancers, including Hilmo

670

5644

0.69

19.24

1.1

1.28

1.57

u/ml

0.59

336

2757

Dorsopathies

1646

6490

1.29

19.23

1.1

1.68

2.14

u/ml

1.21

890

3299

Any event in cancer register

819

6674

0.71

19.16

1.1

1.66

1.64

u/ml

0.02

398

3337

Certain infectious and parasitic diseases, including avohilmo

1067

3915

1.37

19.06

1.1

1.71

1.88

u/ml

0.27

556

1979

Mood [affective] disorders

1519

7547

1.30

19.04

1.1

1.77

1.95

u/ml

0.37

861

3701

Propionic acid derivatives

440

1356

1.65

18.87

1.1

2.00

2.60

u/ml

0.69

236

817

Simple and mucopurulent chronic bronchitis

126

4.13

18.79

1.1

0.21

0.99

u/ml

1.15

Mood disorders

1518

7547

1.29

18.69

1.1

1.77

1.95

u/ml

0.37

861

3700

Early onset COPD

215

1114

1.95

18.61

1.1

1.84

1.03

u/ml

1.39

133

537

Disturbance of activity and attention

451

2827

1.59

18.50

1.2

1.1

2.59

2.76

u/ml

0.12

283

1612

Gastrointestinal diseases

1146

4282

1.35

18.39

1.1

2.17

2.33

u/ml

0.20

613

2211

Pruritus

170

817

2.11

18.27

1.1

1.56

0.88

u/ml

0.42

374

Mouth breathing

527

3492

1.52

18.20

1.1

1.75

1.90

u/ml

0.13

294

1878

Nonsuppurative otitis media, including avohilmo

697

4215

1.45

18.17

1.1

2.07

2.48

u/ml

0.54

410

2254

Other inflammation of eyelid

204

1051

1.97

18.07

1.1

1.71

1.64

u/ml

0.04

113

537

Herpesviral [herpes simplex] infections, including avohilmo

469

3045

1.56

18.06

1.1

2.87

1.74

u/ml

1.15

244

1529

Allergic colitis

123

531

2.51

18.02

1.2

4.40

3.27

u/ml

0.43

356

Cystitis

1202

5408

1.33

17.95

1.1

1.67

1.91

u/ml

0.43

586

2789

Depression medications

741

2595

1.45

17.94

1.1

2.60

2.51

u/ml

0.06

403

1283

Haemorrhage from respiratory passages

295

1500

1.75

17.90

1.1

2.26

1.85

u/ml

0.26

163

734

Diabetes, varying definitions

958

7482

0.74

17.87

1.1

1.36

1.85

u/ml

1.55

507

3752

Hyperkinetic disorders

464

2949

1.57

17.83

1.2

1.1

2.59

2.74

u/ml

0.11

293

1686

Diabetes mellitus

968

7509

0.74

17.71

1.1

1.35

1.85

u/ml

1.62

514

3767

Migraine without aura

470

3095

1.54

17.07

1.1

1.32

2.11

u/ml

1.39

249

1593

Dysphagia

250

1406

1.79

16.75

1.1

1.21

1.17

u/ml

0.04

135

702

Accidents

1224

4686

1.32

16.55

1.1

1.80

2.05

u/ml

0.43

642

2298

Other viral diseases, including avohilmo

773

5564

1.39

16.46

1.1

1.68

2.39

u/ml

1.33

405

2986

Neurological diseases, wide definition

676

2371

1.45

16.16

1.1

1.77

2.66

u/ml

1.59

376

1311

Schizophrenia

1608

0.33

16.07

1.1

1.09

1.86

u/ml

1.12

815

Fenamates

186

642

1.99

16.03

1.1

1.15

1.77

u/ml

0.55

342

Other external causes of accidental injury

1219

4686

1.31

16.02

1.1

1.82

2.05

u/ml

0.38

650

2298

Lichen simplex chronicus and prurigo

303

2.76

15.97

1.1

1.28

0.66

u/ml

0.70

143

Diseases of the ear and mastoid process

1762

7118

1.25

15.48

1.1

1.65

2.02

u/ml

0.97

928

3578

Insulin medication

361

4644

0.64

15.41

1.1

1.24

1.76

u/ml

0.90

199

2432

Mood disorders, excluding more controls

1339

6167

1.28

15.41

1.1

1.79

1.87

u/ml

0.12

753

2943

Suppurative and unspecified otitis media

783

5104

1.37

15.26

1.1

1.71

2.35

u/ml

1.54

440

2716

Functional dyspepsia

347

2187

1.60

15.23

1.1

1.26

1.48

u/ml

0.26

184

1072

Soft tissue disorders related to use, overuse and pressure

302

1839

1.66

15.21

1.1

0.91

1.32

u/ml

0.82

151

879

Exfoliative dermatitis

6.58

15.18

1.1

1.0

11.04

0.46

u/ml

1.92

Later onset COPD, excluding more controls

128

3.41

15.09

1.0

0.21

0.32

u/ml

0.30

Transport accidents

736

4461

1.38

15.06

1.1

1.69

2.07

u/ml

0.58

370

2193

Migraine without aura and triptan purchases

373

2408

1.57

14.95

1.1

1.39

1.75

u/ml

0.37

191

1245

ILD, hospital admissions 1, main diag only

101

426

2.39

14.91

1.1

1.35

1.09

u/ml

0.17

227

Lower back pain or/and sciatica

1520

7559

1.25

14.84

1.1

1.30

1.92

u/ml

2.25

801

3736

Anti-inflammatory and antirheumatic products, non-steroids

419

1358

1.56

14.75

1.1

1.94

2.60

u/ml

0.79

228

819

Non-allergic asthma

405

2.43

14.68

1.1

0.69

1.35

u/ml

0.58

184

Other menopausal disorders

327

1115

1.65

14.61

1.0

1.1

1.07

1.13

u/ml

0.07

157

531

Provisional assignment of new diseases of uncertain etiology

753

5521

1.36

14.35

1.1

1.68

1.86

u/ml

0.24

425

2859

Biguanides

723

5921

0.73

14.31

1.1

1.13

1.51

u/ml

1.11

373

2841

Paracetamol or NSAID medication

306

928

1.68

14.31

1.1

2.21

2.93

u/ml

0.63

179

566

Codes for special purposes

753

5524

1.36

14.29

1.1

1.68

1.86

u/ml

0.24

425

2860

Injuries to the ankle and foot

1222

8229

1.27

14.27

1.1

1.97

2.00

u/ml

0.04

685

4175

Type 2 diabetes

853

6539

0.75

14.24

1.1

1.22

1.63

u/ml

1.38

441

3148

Injuries to the wrist and hand

1515

8089

1.25

14.15

1.1

2.43

1.83

u/ml

1.11

803

4148

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

644

4037

1.39

14.11

1.1

1.05

1.33

u/ml

0.57

347

2011

Other bacterial diseases

745

6626

0.74

13.95

1.1

2.05

1.69

u/ml

0.60

434

3361

Intestinal infectious diseases

1386

8248

1.25

13.91

1.1

2.02

1.98

u/ml

0.05

754

4224

Diseases of oesophagus, stomach and duodenum

1471

6970

1.25

13.90

1.1

1.23

1.88

u/ml

3.37

763

3500

Heartburn

163

854

1.94

13.88

1.1

0.60

1.63

u/ml

3.01

429

Other (not insulin) diabetes medications

784

6138

0.75

13.82

1.1

1.17

1.57

u/ml

1.22

408

2949

Disorders of eyelid, lacrimal system and orbit

1102

6299

1.29

13.69

1.1

1.91

1.72

u/ml

0.27

558

3159

Schizophrenia or delusion

202

3475

0.58

13.65

1.1

0.69

1.87

u/ml

7.66

130

1756

Type 2 diabetes, strict (exclude DM1)

773

5999

0.75

13.61

1.1

1.26

1.57

u/ml

0.82

399

2880

Schizophrenia, schizotypal and delusional disorders

203

3480

0.58

13.54

1.1

0.68

1.86

u/ml

7.73

131

1760

External causes of morbidity and mortality

1030

3966

1.31

13.53

1.1

1.91

2.06

u/ml

0.21

539

1947

Acne, including avohilmo

624

3656

1.40

13.51

1.1

2.37

2.53

u/ml

0.14

333

1993

Subjective visual disturbances

340

2198

1.56

13.46

1.1

2.05

1.63

u/ml

0.38

195

1113

ILD, hospital admissions

108

491

2.22

13.43

1.1

1.31

1.01

u/ml

0.20

267

Other interstitial pulmonary diseases

108

493

2.21

13.30

1.1

1.31

1.01

u/ml

0.21

268

Disorders of synovium and tendon

735

4634

1.35

13.29

1.1

1.37

1.67

u/ml

0.45

342

2267

Type 2 diabetes, definitions combined

775

5988

0.75

13.25

1.1

1.25

1.57

u/ml

0.84

400

2875

Interstitial lung disease

108

494

2.21

13.23

1.1

1.31

1.01

u/ml

0.21

268

Interstitial lung disease endpoints

108

494

2.21

13.23

1.1

1.31

1.01

u/ml

0.21

268

Inflammatory diseases of female pelvic organs

1012

5367

1.30

13.22

1.1

1.91

1.74

u/ml

0.22

501

2624

Other respiratory diseases principally affecting the interstitium

124

600

2.08

13.15

1.1

1.19

1.11

u/ml

0.05

323

1192

5495

1.27

13.11

1.1

1.85

1.76

u/ml

0.12

688

2659

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1192

5495

1.27

13.11

1.1

1.85

1.76

u/ml

0.12

688

2659

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

634

4045

1.39

13.04

1.1

2.51

2.68

u/ml

0.16

379

2236

Kela-code for severe mental illness

238

3874

0.61

12.90

1.1

0.75

1.77

u/ml

4.97

143

1950

Peritonsillar abscess

270

1672

1.63

12.85

1.1

1.0

1.81

2.05

u/ml

0.20

129

735

Visual disturbances

615

4492

1.38

12.79

1.1

1.94

1.93

u/ml

0.01

344

2346

ILD, hospital admission 2, with pulmonary infections

262

2.66

12.76

1.1

0.77

1.46

u/ml

0.68

133

Infective dermatitis

131

656

2.02

12.74

1.1

2.21

1.04

u/ml

0.68

293

Chronic conjunctivitis

226

2.84

12.60

1.1

4.21

1.38

u/ml

0.91

132

Other viral diseases, not elsewhere classified, including avohilmo

533

3794

1.41

12.59

1.1

1.89

2.37

u/ml

0.49

271

2095

COPD, hospital admissions

272

1419

1.62

12.51

1.1

1.50

0.86

u/ml

1.32

165

690

Symptoms and signs involving the skin and subcutaneous tissue

957

7041

1.29

12.50

1.1

1.92

1.69

u/ml

0.36

517

3531

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

111

359

2.19

12.40

1.1

1.33

1.26

u/ml

0.04

186

COPD, early/later onset

274

1430

1.61

12.39

1.1

1.0

1.51

0.87

u/ml

1.36

166

698

Arthropathies

1554

6415

1.23

12.26

1.1

1.71

2.21

u/ml

1.38

814

3325

General symptoms and signs

1607

6601

1.22

12.17

1.1

1.55

2.03

u/ml

1.50

878

3319

Other general symptoms and signs

133

682

1.98

11.96

1.2

1.1

2.52

2.41

u/ml

0.03

404

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1562

6808

1.22

11.90

1.1

1.84

2.02

u/ml

0.32

904

3365

Other noninfective gastroenteritis and colitis

360

2420

1.50

11.90

1.1

2.76

2.28

u/ml

0.35

219

1345

Dermatophytosis, including avohilmo

896

6836

1.29

11.87

1.1

1.55

1.83

u/ml

0.41

434

3460

Type 2 diabetes, definitions combined, including avohilmo

806

6057

0.77

11.82

1.1

1.25

1.58

u/ml

0.93

419

2900

Renal failure

127

2042

0.53

11.80

1.1

1.15

1.42

u/ml

0.33

1080

Nummular dermatitis

384

2.30

11.72

1.1

1.56

0.85

u/ml

0.28

178

Disease of hard tissues of teeth, NOS

607

2310

1.38

11.71

1.1

1.35

1.55

u/ml

0.32

307

1071

Visual disturbances and blindness

639

4759

1.35

11.67

1.1

1.91

1.90

u/ml

0.01

359

2499

Emphysema

119

3.39

11.36

1.2

1.0

2.39

1.36

u/ml

0.32

Other and unspecified nonorganic psychotic disorders

140

2517

0.55

11.29

1.1

0.60

2.00

u/ml

7.82

1293

Acute suppurative otitis media

620

4317

1.35

11.26

1.2

1.1

1.91

2.45

u/ml

0.82

357

2327

Cervicocranial syndrome

141

759

1.88

11.16

1.1

1.65

1.59

u/ml

0.04

354

Disturbances of skin sensation

426

2999

1.43

11.15

1.1

1.93

1.64

u/ml

0.28

237

1478

Acute pharyngitis

327

2170

1.51

11.12

1.1

2.63

2.52

u/ml

0.06

181

1176

Insulin, combination of fast acting with intermediate-acting or long-acting

361

4737

0.69

11.10

1.1

1.24

1.76

u/ml

0.91

199

2486

Follow-up examination after treatment for conditions other than malignant neoplasms

577

2818

1.37

11.08

1.1

1.20

1.83

u/ml

1.41

309

1245

Generalized anxiety disorder

370

2543

1.47

11.04

1.1

1.95

2.38

u/ml

0.41

225

1257

Unspecified threat to breathing

104

3.72

11.01

1.2

1.1

2.96

2.30

u/ml

0.13

Enthesopathies of lower limb, excluding foot

304

2009

1.53

10.99

1.1

1.96

1.66

u/ml

0.25

155

956

Persons encountering health services in other circumstances, wide

1598

6808

1.21

10.96

1.1

1.90

2.02

u/ml

0.19

902

3365

Prurigo nodularis

3.80

10.92

1.1

1.0

1.08

0.49

u/ml

0.53

Unspecified privation

151

838

1.83

10.88

1.1

1.46

1.53

u/ml

0.05

101

419

All chronic kidney diseases

297

3539

0.67

10.76

1.1

2.16

1.89

u/ml

0.19

164

1889

Other nutritional deficiencies

993

7235

1.26

10.75

1.1

1.64

1.86

u/ml

0.39

545

3591

COPD, hospital admissions 1, only main diagnosis

188

951

1.71

10.64

1.1

1.59

0.99

u/ml

0.83

114

478

Schizophrenia or delusion, excluding more controls

202

3215

0.62

10.62

1.1

0.69

1.68

u/ml

5.81

130

1563

Malignant neoplasm of breast

242

2433

0.64

10.60

1.1

1.42

1.14

u/ml

0.27

120

1112

Injuries to the knee and lower leg

1717

7788

1.20

10.43

1.1

1.75

1.98

u/ml

0.44

892

3981

Malignant neoplasm of breast, HER2-negative

243

2431

0.64

10.41

1.1

1.41

1.14

u/ml

0.26

121

1111

Pain in limb

1205

6227

1.23

10.40

1.1

1.72

2.06

u/ml

0.67

624

3211

Other diseases of intestines

1654

7717

1.20

10.33

1.1

1.60

2.11

u/ml

1.50

834

4013

Vocal cord dysfunction

218

1191

1.63

10.23

1.2

1.1

1.42

1.57

u/ml

0.08

122

554

Somatoform disorder

246

1582

1.57

10.16

1.2

1.1

0.97

1.80

u/ml

2.09

130

737

Excessive attrition of teeth

942

7455

1.26

10.15

1.1

1.49

1.97

u/ml

0.99

494

3743

Periodontitis

825

6669

0.78

10.14

1.1

1.57

1.55

u/ml

0.02

456

3207

Diaphragmatic hernia

280

1850

1.52

10.11

1.1

1.23

1.04

u/ml

0.20

154

910

Other bacterial diseases, including avohilmo

983

7622

0.80

10.03

1.1

2.06

1.82

u/ml

0.41

572

3840

Trochanteric bursitis

151

859

1.77

9.99

1.1

0.53

1.41

u/ml

2.60

407

Irregular menses

883

5255

1.27

9.99

1.1

1.47

1.98

u/ml

1.11

436

2558

Type 2 diabetes, wide definition

477

4097

0.73

9.94

1.1

0.99

1.31

u/ml

0.68

257

1941

Diseases of external ear

439

3173

1.39

9.90

1.1

1.97

1.98

u/ml

0.00

251

1672

Other diseases of oesophagus

413

2.13

9.86

1.1

0.81

1.52

u/ml

0.84

216

Oedema, not elsewhere classified

334

2245

1.46

9.84

1.1

1.35

1.58

u/ml

0.23

185

1106

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

130

714

1.85

9.75

1.2

1.1

1.42

1.64

u/ml

0.16

366

Otitis externa

328

2259

1.47

9.75

1.1

1.91

1.73

u/ml

0.16

183

1189

Unspecified mental disorder

316

4556

0.69

9.72

1.1

1.10

1.78

u/ml

1.57

188

2297

Cerebrovascular diseases

322

3228

0.69

9.70

1.1

0.93

1.13

u/ml

0.28

151

1606

Chronic periodontitis, including avohilmo

827

6653

0.79

9.69

1.1

1.57

1.55

u/ml

0.01

456

3199

Disorders of skin appendages

796

6248

1.27

9.68

1.1

1.96

2.09

u/ml

0.16

448

3191

Malignant neoplasm of breast, including Hilmo

259

2499

0.66

9.67

1.1

1.33

1.17

u/ml

0.15

133

1136

Other enthesopathies

360

2525

1.43

9.64

1.1

0.96

1.43

u/ml

1.02

174

1189

Dipeptidyl peptidase 4 (DPP-4) inhibitors

181

2302

0.61

9.62

1.1

0.83

1.13

u/ml

0.56

1130

Rosacea

181

1096

1.67

9.61

1.1

1.39

1.60

u/ml

0.22

100

524

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

348

2435

1.45

9.57

1.1

2.62

1.74

u/ml

0.86

172

1214

Dislocation, sprain and strain of joints and ligaments of knee

950

6916

1.25

9.53

1.1

1.67

1.82

u/ml

0.24

489

3410

Malignant neoplasm of breast, HER2-negative, including Hilmo

260

2499

0.66

9.52

1.1

1.32

1.17

u/ml

0.14

134

1136

Alcohol dependence

104

1935

0.53

9.45

1.1

0.55

1.55

u/ml

4.44

953

Restless leg syndrome

171

1025

1.69

9.43

1.1

1.15

1.44

u/ml

0.29

500

Female infertility, cervical, vaginal, other or unspecified origin

449

2080

1.39

9.42

1.1

1.50

1.87

u/ml

0.62

222

1060

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

486

3603

1.36

9.42

1.1

2.52

1.86

u/ml

0.44

268

1865

Oxicams

203

703

1.65

9.39

1.1

0.72

1.60

u/ml

2.54

102

378

Organic, including symptomatic, mental disorders

105

1378

0.53

9.38

1.0

1.1

0.41

0.91

u/ml

2.41

705

Internal derangement of knee

461

3356

1.37

9.34

1.1

1.37

1.63

u/ml

0.32

230

1639

Chronic gastritis

178

1082

1.65

9.23

1.1

0.96

1.24

u/ml

0.36

101

522

Fibromyalgia

151

882

1.74

9.22

1.1

1.64

1.56

u/ml

0.04

408

Ganglion

303

2080

1.47

9.19

1.1

1.24

1.69

u/ml

0.58

155

998

Unspecified acute lower respiratory infection

204

1288

1.60

9.16

1.2

1.1

2.18

1.80

u/ml

0.24

128

652

Dermatitis due to substances taken internally

380

2.14

9.15

1.1

4.40

0.82

u/ml

1.30

179

Other and unspecified tonsillitis

664

4280

1.30

9.14

1.1

1.64

2.12

u/ml

0.83

354

2216

Endometriosis of pelvic peritoneum

254

1539

1.52

8.85

1.1

0.71

1.74

u/ml

3.41

108

782

Mental and behavioural disorders due to alcohol, excluding acute intoxication

261

3793

0.68

8.81

1.1

1.91

1.68

u/ml

0.15

161

1885

Heart failure, not strict

381

3534

0.72

8.77

1.1

0.74

1.37

u/ml

2.67

207

1782

Excessive, frequent and irregular menstruation

627

2569

1.31

8.70

1.1

1.66

2.38

u/ml

1.19

313

1370

COPD related to multimorbidity

199

1060

1.59

8.69

1.1

1.0

1.47

0.82

u/ml

1.06

120

519

Panic disorder

303

2109

1.45

8.65

1.1

1.40

2.06

u/ml

1.42

183

1029

Other and unspecified rosacea

125

705

1.80

8.65

1.1

1.64

1.36

u/ml

0.22

325

Inflammatory diseases of prostate (prostatitis)

108

582

1.87

8.60

1.1

1.68

2.07

u/ml

0.14

307

Psychiatric diseases

1291

5382

1.21

8.58

1.1

1.89

1.90

u/ml

0.02

702

2685

Other diseases of lip and oral mucosa

502

3792

1.33

8.57

1.1

1.93

1.65

u/ml

0.28

273

1911

Alcohol use disorder, ICD-based

240

3553

0.67

8.54

1.1

1.94

1.74

u/ml

0.12

148

1766

Acute laryngitis and tracheitis

274

1851

1.48

8.44

1.2

1.1

2.63

2.54

u/ml

0.05

162

1023

Vasomotor rhinitis (mode)

468

1.97

8.41

1.1

3.36

1.63

u/ml

0.49

243

COPD, hospital admission 2, with asthma infections

176

939

1.62

8.30

1.1

1.33

1.02

u/ml

0.38

112

466

Tinnitus

244

1640

1.50

8.26

1.1

1.19

1.28

u/ml

0.06

125

812

Malignant neoplasm of digestive organs, including Hilmo

129

1603

0.59

8.17

1.1

1.59

1.06

u/ml

0.36

786

Insulin, intermediate and long-acting

323

4340

0.71

8.16

1.1

1.35

1.75

u/ml

0.56

179

2267

Diarrhoea and gastroenteritis of presumed infectious origin

1023

7544

1.21

8.09

1.1

1.68

2.04

u/ml

0.67

562

3902

Injury, poisoning and certain other consequences of external causes

823

3302

1.25

8.06

1.1

1.81

1.97

u/ml

0.22

435

1622

Other diseases of hard tissues of teeth

591

2352

1.31

8.05

1.1

1.24

1.61

u/ml

0.71

304

1105

Stroke, including SAH

226

2412

0.67

8.05

1.1

1.20

1.12

u/ml

0.07

109

1212

Oesophagitis

255

2.31

8.04

1.2

1.1

1.14

1.57

u/ml

0.29

133

448

5156

0.75

8.03

1.1

1.99

1.72

u/ml

0.25

268

2574

Female infertility

481

2166

1.34

7.99

1.1

1.37

1.95

u/ml

1.40

239

1112

Other degenerative diseases of the nervous system

1173

0.53

7.88

1.0

1.1

0.66

1.19

u/ml

0.60

556

Other/unspecified dorsalgia

443

3287

1.34

7.87

1.1

0.90

1.69

u/ml

3.38

261

1603

Substance abuse

448

5478

0.76

7.78

1.1

2.11

1.67

u/ml

0.49

271

2751

Hypertrophy of breast in women and men

274

1909

1.45

7.78

1.1

1.58

1.41

u/ml

0.13

132

913

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1036

0.44

7.77

1.0

1.1

0.42

1.01

u/ml

1.09

488

Other contact dermatitis

103

568

1.84

7.72

1.1

3.13

1.06

u/ml

1.13

254

414

4910

0.75

7.66

1.1

2.10

1.73

u/ml

0.34

251

2461

Selective deficiency of immunoglobulin G [IgG] subclasses

4.64

7.55

1.1

6.88

0.99

u/ml

0.61

Mental and behavioural disorders due to psychoactive substance use

471

5615

0.76

7.54

1.1

2.20

1.69

u/ml

0.58

282

2821

Urinary track infection

979

4031

1.22

7.53

1.1

1.73

1.91

u/ml

0.25

481

2034

Factors influencing health status and contact with health services

373

1358

1.39

7.47

1.1

1.68

2.19

u/ml

0.58

208

571

Appendicitis, broad definition

986

7342

1.21

7.46

1.1

1.95

1.64

u/ml

0.47

471

3617

Diseases of appendix

990

7353

1.21

7.41

1.1

1.97

1.64

u/ml

0.53

473

3625

Acute tubulo-interstitial nephritis

475

5204

0.77

7.40

1.1

1.45

1.89

u/ml

0.72

260

2693

Acute appendicitis, no complications

798

6464

1.23

7.40

1.1

1.95

1.72

u/ml

0.27

376

3181

ILD, hospital admissions 3, with pneumonia sepsis

228

2.30

7.26

1.1

0.43

1.01

u/ml

1.03

117

Noninfective enteritis and colitis

629

5000

1.26

7.25

1.1

2.40

2.03

u/ml

0.40

355

2655

Alcohol use disorder, Swedish definition

362

4415

0.74

7.24

1.1

1.57

1.66

u/ml

0.07

220

2174

Genitourinary diseases

884

3626

1.23

7.17

1.1

1.67

2.55

u/ml

2.41

480

2042

Other and unspecified drugs and medicaments

110

634

1.76

7.15

1.2

1.1

1.13

1.73

u/ml

0.58

321

Unspecified chronic bronchitis

3.46

7.12

1.3

1.0

2.45

1.98

u/ml

0.08

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1042

7962

1.20

7.10

1.1

1.96

2.07

u/ml

0.15

562

4063

Stroke, excluding SAH

199

2132

0.67

7.09

1.1

1.22

1.15

u/ml

0.06

100

1069

Superficial injury of lower leg

375

2801

1.35

7.05

1.1

2.37

2.15

u/ml

0.14

198

1467

Dislocation, sprain and strain of joints and ligaments at neck level

273

1940

1.42

7.04

1.1

2.56

1.90

u/ml

0.47

143

987

Chondrocostal junction syndrome [Tietze]

272

2.18

6.98

1.1

3.20

1.98

u/ml

0.33

141

Mental and behavioural disorders due to alcohol

362

4596

0.75

6.96

1.1

2.31

1.77

u/ml

0.46

218

2297

Dental pulpitis, including avohilmo

1392

7643

1.17

6.95

1.1

1.63

1.94

u/ml

0.64

736

3771

Adenomyosis (Endometriosis of uterus)

143

890

1.62

6.88

1.1

0.89

1.25

u/ml

0.50

429

Acute appendicitis

934

7224

1.20

6.84

1.1

1.85

1.65

u/ml

0.27

448

3554

Other respiratory disorders and diseases

137

846

1.63

6.82

1.1

1.27

1.49

u/ml

0.17

451

Other diseases of the respiratory system

137

846

1.63

6.82

1.1

1.27

1.49

u/ml

0.17

451

Otalgia

140

873

1.63

6.80

1.2

1.1

2.51

2.00

u/ml

0.19

496

Ovarian cyst

509

2256

1.30

6.78

1.1

1.20

1.96

u/ml

1.95

280

1166

Any gastric operation

1332

5713

1.17

6.65

1.1

1.91

2.29

u/ml

0.70

697

2989

GASTRO-related operations

1332

5713

1.17

6.65

1.1

1.91

2.29

u/ml

0.70

697

2989

Dementia, including avohilmo

811

0.50

6.65

1.0

1.1

0.26

0.82

u/ml

1.82

437

Pain in thoracic spine

199

1347

1.49

6.64

1.1

1.49

1.63

u/ml

0.14

101

641

Cervicalgia

222

1534

1.46

6.64

1.1

1.53

1.39

u/ml

0.10

110

721

Striking against or struck by other objects

535

4223

1.27

6.62

1.1

2.17

2.18

u/ml

0.01

302

2294

Other extrapyramidal and movement disorders in other diseases

229

1593

1.45

6.60

1.1

1.55

1.32

u/ml

0.23

112

789

Other bacterial intestinal infections, including avohilmo

248

1754

1.42

6.54

1.1

0.92

1.84

u/ml

2.53

136

890

Anomalies of dental arch relationship, including avohilmo

396

2726

1.33

6.54

1.1

1.59

2.76

u/ml

2.25

212

1526

Peripheral artery disease

1147

0.56

6.53

1.1

0.19

0.85

u/ml

4.99

585

Disorders of tooth development and eruption

266

1546

1.41

6.48

1.1

1.28

2.00

u/ml

0.73

128

755

Other disorders of eye and adnexa

209

1437

1.47

6.48

1.1

1.70

1.71

u/ml

0.00

121

750

Drug-induced adrenocortical insufficiency

136

2.65

6.46

1.2

1.1

0.51

0.76

u/ml

0.28

Liquid cancers, including Hilmo

137

1888

0.64

6.44

1.1

1.65

1.28

u/ml

0.21

976

Obesity

896

7050

1.20

6.43

1.1

1.52

1.85

u/ml

0.64

496

3475

Any dementia

594

0.43

6.41

1.0

1.1

0.20

0.68

u/ml

2.27

323

Obesity and other hyperalimentation

897

7053

1.20

6.38

1.1

1.52

1.84

u/ml

0.65

497

3476

Herpesviral [herpes simplex] infections

157

1021

1.55

6.37

1.1

3.81

1.34

u/ml

1.40

519

Diseases of oral cavity, salivary glands and jaws

577

2353

1.27

6.35

1.1

1.42

1.61

u/ml

0.27

313

1105

Diseases of salivary glands

390

2977

1.32

6.35

1.1

1.30

1.73

u/ml

0.48

196

1496

Any dementia, excluding more controls

587

0.43

6.33

1.0

1.1

0.20

0.76

u/ml

1.71

309

General examination and investigation of persons without complaint and reported diagnosis

791

3368

1.22

6.33

1.1

1.95

2.00

u/ml

0.06

443

1508

Viral and other specified intestinal infections, including avohilmo

566

4359

1.26

6.32

1.1

2.83

2.46

u/ml

0.25

312

2386

Postmenopausal atrophic vaginitis

197

717

1.50

6.31

1.1

0.79

0.93

u/ml

0.11

332

Malaise and fatigue

591

3726

1.25

6.30

1.1

1.07

1.86

u/ml

2.77

323

1919

3.89

6.28

1.2

1.0

0.22

0.31

u/ml

—

Other diseases of urinary system

1273

6126

1.17

6.27

1.1

1.63

1.94

u/ml

0.63

632

3169

Nonorganic sleeping disorders, excluding more controls

344

2587

1.34

6.26

1.1

2.02

1.99

u/ml

0.02

181

1273

Hypertrophy of breast

245

1746

1.42

6.25

1.1

1.63

1.35

u/ml

0.21

116

825

Infections of the skin and subcutaneous tissue

820

6711

1.21

6.25

1.1

1.96

2.04

u/ml

0.10

480

3497

Condition for Implicit Sepsis (Organ dysfunction codes)

733

6161

0.82

6.24

1.1

1.86

1.73

u/ml

0.17

385

3167

Persons encountering health services in other circumstances

574

4558

1.25

6.23

1.1

1.85

2.14

u/ml

0.35

279

2324

Other disorders of white blood cells

312

2.02

6.21

1.2

1.1

2.13

2.09

u/ml

0.01

166

Viral warts, including avohilmo

365

2774

1.33

6.19

1.1

2.26

2.23

u/ml

0.01

158

1512

Ocular pain

131

824

1.61

6.18

1.1

0.81

1.56

u/ml

1.31

426

Other disorders of adrenal gland

413

1.88

6.11

1.2

1.1

0.60

2.27

u/ml

2.98

238

Malignant neoplasm of breast, ER-positive, including Hilmo

167

1845

0.67

6.10

1.1

1.55

1.06

u/ml

0.41

849

Lichen simplex chronicus

170

2.39

6.09

1.1

1.64

0.69

u/ml

0.46

Degenerative diseases of the nervous system

543

0.41

6.08

1.1

0.20

0.71

u/ml

2.23

296

Postviral fatigue syndrome

118

2.79

6.08

1.2

1.1

0.80

1.50

u/ml

0.48

Substance abuse, excluding more controls

448

4765

0.78

6.07

1.1

2.11

1.78

u/ml

0.33

271

2278

Falls/tendency to fall

1599

6993

1.15

6.06

1.1

1.84

2.02

u/ml

0.31

855

3521

Any operation in hilmo

209

1.93

6.06

1.1

2.05

2.73

u/ml

0.22

Covid-19 confirmed case

385

2949

1.31

6.05

1.1

1.88

1.74

u/ml

0.11

208

1521

Sulfonylureas

686

0.45

6.04

1.0

1.1

2.23

0.86

u/ml

0.75

346

Other otitis externa (chronic)

532

1.75

6.00

1.1

2.27

1.74

u/ml

0.21

285

Noninflammatory disorders of female genital tract

643

2607

1.24

5.98

1.1

1.90

2.37

u/ml

0.62

327

1399

Malignant neoplasm of breast, HER-positive

167

1838

0.67

5.95

1.1

1.55

1.05

u/ml

0.41

845

Disorders of the thyroid gland

1209

6738

1.17

5.94

1.1

1.59

1.76

u/ml

0.26

571

3433

Malignant neoplasm of digestive organs

115

1403

0.62

5.90

1.1

1.10

1.06

u/ml

0.03

700

STROKE

353

3112

0.76

5.88

1.1

1.52

1.28

u/ml

0.25

183

1508

Other and unspecified vaccines and biological substances

3.54

5.86

1.2

1.1

2.63

2.39

u/ml

0.04

Seborrhoeic dermatitis

580

1.70

5.85

1.1

2.41

0.77

u/ml

0.44

281

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

819

5313

1.20

5.83

1.1

1.50

1.58

u/ml

0.09

365

2582

Universal erythroderma, KELA reimbursement

3.23

5.80

1.1

11.42

1.98

u/ml

1.63

Unspecific neurodegenerative disorder

583

0.46

5.78

1.1

0.21

0.53

u/ml

1.36

324

Pulmonary eosinophilia, not elsewhere classified

4.01

5.76

1.2

1.0

0.29

0.35

u/ml

0.09

Benign neoplasm: Colon, unspecified

147

964

1.53

5.73

1.1

1.52

0.96

u/ml

0.43

468

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

575

4651

1.24

5.70

1.1

1.48

1.46

u/ml

0.02

307

2308

Other disorders of breast

186

1285

1.46

5.68

1.1

1.14

1.36

u/ml

0.17

103

622

Hypothyroidism, other/unspecified

1129

6370

1.17

5.67

1.1

1.40

1.75

u/ml

0.78

528

3245

Acute and transient psychotic disorders

1126

0.54

5.66

1.1

0.75

1.64

u/ml

1.61

551

Covid-19 suspected case

354

2716

1.31

5.65

1.1

1.48

1.88

u/ml

0.49

213

1388

Dysplasia of cervi uteri

365

1964

1.32

5.64

1.1

1.73

1.83

u/ml

0.07

162

987

Chronic kidney disease

1345

0.58

5.63

1.1

1.32

1.45

u/ml

0.09

712

Other and unspecified polyneuropathies, also in other diseases

126

802

1.58

5.63

1.2

1.1

1.60

1.15

u/ml

0.26

391

Mental retardation, wide definition

735

0.43

5.60

1.2

1.68

3.03

u/ml

0.38

497

Erosion of teeth , including avohilmo

444

3512

1.27

5.58

1.1

1.92

2.11

u/ml

0.15

244

1832

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

383

1.87

5.57

1.2

1.1

2.12

1.65

u/ml

0.21

204

Recurrent aphthous stomatitis , including avohilmo

194

1357

1.44

5.55

1.1

2.02

1.93

u/ml

0.02

100

739

Ischaemic Stroke, excluding all haemorrhages

179

1896

0.69

5.53

1.1

1.29

1.08

u/ml

0.19

946

Disorders of thyroid, IBD co-morbidities

271

1363

1.37

5.48

1.1

2.69

1.95

u/ml

0.47

134

700

Tramadol

933

4750

1.18

5.48

1.1

0.93

1.76

u/ml

3.23

496

2296

Dialysis, with operation codes

811

0.46

5.48

1.0

1.1

0.58

1.41

u/ml

2.77

449

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

784

0.46

5.46

1.1

0.85

1.07

u/ml

0.14

366

Urticaria due to cold and heat

3.05

5.42

1.3

1.0

3.00

2.30

u/ml

0.15

Septicaemia

207

2629

0.72

5.41

1.1

2.00

1.80

u/ml

0.13

134

1419

Infections with a predominantly sexual mode of transmission, including avohilmo

764

5861

1.20

5.41

1.1

1.95

2.19

u/ml

0.27

387

2976

Candidiasis

180

1249

1.45

5.39

1.1

1.70

1.37

u/ml

0.19

628

Disorders of breast

661

4812

1.21

5.36

1.1

1.49

1.62

u/ml

0.14

337

2284

Appendectomy

889

7191

1.18

5.36

1.1

1.78

1.70

u/ml

0.10

439

3528

Certain infectious and parasitic diseases

1412

6181

1.15

5.35

1.1

2.11

2.01

u/ml

0.14

758

3111

Shoulder lesions

792

3972

1.20

5.33

1.1

1.01

1.47

u/ml

1.22

398

1885

Mental retardation

719

0.44

5.32

1.2

1.68

3.06

u/ml

0.39

490

Adrenocortical insufficiency

276

1.99

5.26

1.2

1.1

0.55

1.44

u/ml

1.63

146

Nausea and vomiting

322

2400

1.31

5.25

1.1

1.25

2.27

u/ml

1.98

190

1355

Toxic effect of contact with venomous animals

362

1.86

5.21

1.0

1.1

1.28

1.56

u/ml

0.17

194

Crossbite

203

1337

1.42

5.21

1.1

1.2

1.71

3.30

u/ml

2.78

140

842

Injury of muscle and tendon at shoulder and upper arm level

279

2093

1.34

5.20

1.1

1.42

1.21

u/ml

0.11

135

1027

Endometriosis

458

2112

1.27

5.20

1.1

0.93

1.88

u/ml

2.50

212

1079

Allergic contact dermatitis due to drugs in contact with skin

139

2.43

5.20

1.1

4.24

1.34

u/ml

0.79

Spondylolisthesis/Spondylolysis

169

1167

1.46

5.18

1.1

0.54

1.46

u/ml

3.51

543

Rotator cuff syndrome

568

3186

1.23

5.17

1.1

1.01

1.33

u/ml

0.52

280

1482

Unspecified/other endometriosis

177

1211

1.45

5.16

1.1

1.31

2.01

u/ml

0.65

614

Other disorders of urethra and urinary system

846

4982

1.18

5.15

1.1

1.93

1.70

u/ml

0.27

416

2516

Hypothyreosis and Thyroxine purchase for inclusion criteria

1159

6581

1.16

5.14

1.1

1.42

1.76

u/ml

0.75

538

3347

Dementia

728

0.54

5.13

1.0

1.1

0.27

0.75

u/ml

1.40

395

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

252

2.03

5.09

1.1

0.91

1.40

u/ml

0.42

117

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

735

3877

1.20

5.09

1.1

1.86

1.94

u/ml

0.09

385

1874

Acute renal failure

948

0.53

5.06

1.0

1.1

1.12

1.28

u/ml

0.13

489

Other reaction to severe stress, and adjustment disorders

601

4963

1.22

5.06

1.1

1.97

2.05

u/ml

0.08

351

2404

COPD-related respiratory insufficiency

286

1.93

5.05

1.1

1.42

0.95

u/ml

0.27

149

Redundant prepuce, phimosis and paraphimosis

246

1793

1.36

5.03

1.1

1.18

2.57

u/ml

3.50

145

979

Disorders of other endocrine glands

583

4728

1.22

5.03

1.1

1.46

2.10

u/ml

1.43

323

2556

Hypothyroidism, strict autoimmune

968

5445

1.17

5.02

1.1

1.48

1.78

u/ml

0.53

446

2749

Alzheimer disease

373

0.36

4.99

1.1

0.20

0.29

u/ml

0.33

210

Other diseases of intestine

115

739

1.56

4.99

1.1

1.24

1.33

u/ml

0.05

376

Diseases of male genital organs

561

2297

1.23

4.98

1.1

1.27

2.35

u/ml

2.94

307

1304

Erysipelas, including avohilmo

517

4687

0.81

4.93

1.1

2.20

1.41

u/ml

1.49

303

2270

Cervicobrachial syndrome

245

1821

1.35

4.91

1.2

1.1

1.18

1.39

u/ml

0.22

132

841

Sub-endpoint used in defining T1D endpoints

228

3021

0.74

4.90

1.1

1.42

2.15

u/ml

0.86

127

1642

Immunodeficiencies

429

1.75

4.88

1.1

2.13

1.95

u/ml

0.05

240

Valvular heart disease excluding rheumatic fever

228

2202

0.74

4.88

1.1

0.96

1.71

u/ml

1.33

123

1161

Certain disorders involving the immune mechanism

212

1543

1.38

4.87

1.1

2.70

1.52

u/ml

0.61

119

787

Blepharochalasis

168

1173

1.44

4.86

1.1

0.44

0.95

u/ml

2.22

566

Menorrhagia

422

1863

1.27

4.86

1.1

1.60

1.70

u/ml

0.09

200

950

Otitis externa, unspecified

164

1143

1.45

4.86

1.1

2.06

1.81

u/ml

0.14

597

Alzheimer disease, including avohilmo

446

0.43

4.85

1.1

0.16

0.34

u/ml

0.82

252

Stomatitis and related lesions

271

2050

1.33

4.85

1.1

2.20

1.81

u/ml

0.17

148

1083

Schizoaffective disorder

798

0.50

4.84

1.1

0.84

1.47

u/ml

1.03

393

Disorders of sclera, cornea, iris and ciliary body

648

5416

1.20

4.84

1.1

2.33

1.67

u/ml

0.93

340

2738

Transplanted organ and tissue status

864

0.52

4.82

1.0

1.1

0.38

1.90

u/ml

6.47

491

All influenza

302

2319

1.31

4.82

1.1

2.25

1.83

u/ml

0.23

170

1260

Radiculopathy

124

817

1.53

4.82

1.2

1.1

1.25

1.44

u/ml

0.11

371

Viral pneumonia

145

988

1.48

4.81

1.1

2.17

1.56

u/ml

0.29

528

Crowding of teeth, including avohilmo

273

1714

1.34

4.81

1.2

1.1

3.69

3.29

u/ml

0.21

190

1049

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

344

1.84

4.77

1.1

2.24

1.52

u/ml

0.26

200

Other intervertebral disc disorders

960

4920

1.17

4.75

1.1

1.20

1.66

u/ml

1.25

496

2345

Fissure and fistula of anal and rectal regions

260

1961

1.33

4.74

1.1

2.04

1.52

u/ml

0.30

119

979

Other disorders of eyelid

281

2018

1.32

4.72

1.1

1.64

1.09

u/ml

0.43

136

984

Hypermobility syndrome

110

713

1.57

4.72

1.2

1.1

1.23

1.82

u/ml

0.58

346

Nonsuppurative otitis media

471

3317

1.24

4.71

1.1

1.97

2.79

u/ml

1.20

292

1833

Other septicaemia, including avohilmo

181

2358

0.72

4.70

1.1

1.99

1.82

u/ml

0.09

115

1266

Speech therapy

229

1697

1.36

4.70

1.1

0.63

1.45

u/ml

3.10

143

846

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

195

1391

1.40

4.68

1.2

1.1

2.90

2.39

u/ml

0.22

108

845

Other disorders of patella

234

1743

1.35

4.67

1.1

1.07

1.38

u/ml

0.43

111

843

Nephropathy related operations

803

0.51

4.67

1.0

1.1

0.48

1.42

u/ml

3.55

444

Cholinergic urticaria

4.79

4.66

1.2

1.0

1.78

0.74

u/ml

—

Other immunodeficiencies

116

2.51

4.66

1.1

1.99

1.41

u/ml

0.18

Uterine polyps

286

1267

1.32

4.64

1.1

1.50

1.23

u/ml

0.19

150

615

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

683

5687

1.19

4.64

1.1

2.03

2.23

u/ml

0.23

376

2958

Diseases of arteries, arterioles and capillaries

300

2838

0.77

4.59

1.1

1.23

1.14

u/ml

0.06

152

1426

Explicit Sepsis

256

3062

0.76

4.59

1.1

1.87

1.80

u/ml

0.04

159

1636

Explicit Sepsis, including avohilmo

265

3140

0.76

4.59

1.1

1.83

1.78

u/ml

0.04

163

1670

Trigger finger

146

1007

1.46

4.57

1.1

1.15

1.39

u/ml

0.19

473

Other specified/unspecified soft tissue disorders

227

2.00

4.56

1.1

1.0

2.06

1.51

u/ml

0.20

113

Myotonic disorders

3.27

4.56

1.2

1.1

2.41

1.71

u/ml

—

Other obstetric conditions, not elsewhere classified

737

3938

1.19

4.55

1.1

1.92

2.01

u/ml

0.09

385

1897

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

936

0.55

4.55

1.1

1.90

2.14

u/ml

0.14

482

Heart failure, strict

173

1678

0.71

4.54

1.1

0.69

0.99

u/ml

0.52

873

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

742

0.50

4.52

1.1

0.60

1.32

u/ml

0.73

366

Faecal incontinence

386

1.75

4.49

1.1

1.0

1.36

1.44

u/ml

0.02

189

Nonorganic sleeping disorders

344

2718

1.27

4.47

1.1

2.02

1.96

u/ml

0.05

181

1383

Sciatica+with lumbago

580

4276

1.20

4.46

1.1

1.38

1.61

u/ml

0.31

324

2016

Type 1 diabetes

229

3031

0.75

4.46

1.1

1.41

2.15

u/ml

0.87

128

1630

Other symptoms and signs involving the circulatory and respiratory systems

380

1.75

4.45

1.1

0.68

1.85

u/ml

1.82

186

Deforming dorsopathies

322

2522

1.28

4.45

1.1

1.07

2.01

u/ml

2.83

168

1280

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1086

7831

0.87

4.44

1.1

1.90

1.95

u/ml

0.05

569

4024

Inflammatory disease of uterus

224

1673

1.35

4.44

1.2

1.1

1.77

1.66

u/ml

0.08

118

809

Presence of cardiac and vascular implants and grafts

119

1299

0.67

4.44

1.1

1.77

0.90

u/ml

0.42

678

Extrapyramidal and movement disorders

296

2294

1.29

4.44

1.1

1.45

1.28

u/ml

0.20

149

1144

Injury of muscle and tendon at hip and thigh level

122

818

1.50

4.44

1.1

1.39

1.46

u/ml

0.03

390

Other septicaemia

177

2297

0.72

4.40

1.1

2.01

1.84

u/ml

0.09

113

1231

Defects in the complement system

2.77

4.35

1.1

1.98

0.78

u/ml

0.34

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

905

7041

0.86

4.33

1.1

1.82

1.90

u/ml

0.10

470

3593

Embedded and impacted teeth

624

4263

1.20

4.32

1.1

2.31

2.48

u/ml

0.11

349

2299

Vulvovaginal ulceration/inflammation in other diseases

128

874

1.48

4.31

1.1

1.92

1.64

u/ml

0.09

429

L04AD Calcineurin inhibitors

1111

0.60

4.31

1.0

1.1

3.52

1.78

u/ml

0.72

621

Disorders of muscles

119

799

1.50

4.30

1.1

0.81

1.53

u/ml

1.06

383

Care involving use of rehabilitation procedures

738

5663

1.17

4.30

1.1

1.50

1.87

u/ml

0.47

438

2797

Heart failure,strict

170

1643

0.72

4.29

1.1

0.71

1.04

u/ml

0.61

851

Post-traumatic stress disorder

185

1351

1.39

4.28

1.2

1.1

1.90

2.14

u/ml

0.13

102

678

Other disorders of bone

263

2020

1.31

4.28

1.1

2.08

1.77

u/ml

0.17

141

1036

Lumbar disc prolapse

720

4537

1.18

4.25

1.1

1.35

1.63

u/ml

0.48

380

2158

Atherosclerosis, excluding cerebral and coronary sclerosis

925

0.61

4.25

1.1

0.25

0.82

u/ml

2.92

479

Complications of medical and surgical care

799

6171

1.17

4.24

1.1

1.40

1.58

u/ml

0.28

423

3035

Epiphora

2.60

4.24

1.0

0.31

1.31

u/ml

—

Spinal osteochondrosis

2.82

4.24

1.2

1.1

1.33

2.67

u/ml

0.49

Nonalcoholic fatty liver disease

124

843

1.48

4.24

1.1

1.56

u/ml

0.00

403

Alcohol withdrawal state with delirium

343

0.29

4.24

1.1

0.74

1.34

u/ml

—

170

Other functional intestinal disorders

509

3831

1.21

4.18

1.1

1.26

2.07

u/ml

2.30

268

2054

All-cause Heart Failure

171

1638

0.72

4.17

1.1

0.58

0.99

u/ml

0.95

854

Benign neoplasm: Ascending colon

502

1.62

4.16

1.1

2.19

1.01

u/ml

0.50

254

Implicit Sepsis

578

5061

0.84

4.14

1.1

1.70

1.68

u/ml

0.01

310

2605

Benign neoplasm of middle ear and respiratory system

374

1.73

4.12

1.1

0.88

1.61

u/ml

0.64

197

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

607

5021

1.19

4.12

1.1

1.42

1.49

u/ml

0.08

322

2488

Symptoms and signs involving the nervous and musculoskeletal systems

638

5408

1.18

4.11

1.1

1.98

1.77

u/ml

0.22

355

2821

Other shoulder lesions

120

816

1.48

4.11

1.1

1.47

1.66

u/ml

0.15

385

Keratitis

420

3428

1.23

4.09

1.1

2.77

1.71

u/ml

1.25

224

1719

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

202

2.01

4.09

1.1

0.41

2.11

u/ml

2.24

106

Dyshidrosis [pompholyx]

136

2.26

4.08

1.1

0.72

0.99

u/ml

0.30

Other arthrosis

486

2682

1.22

4.07

1.1

0.78

1.31

u/ml

1.64

253

1249

Superficial injury of hip and thigh

136

948

1.44

4.06

1.1

3.04

1.47

u/ml

0.61

484

Mental retardation, excluding more controls

619

0.49

4.06

1.2

1.76

2.47

u/ml

0.17

407

Other symptoms and signs involving the nervous and musculoskeletal systems

485

4019

1.21

4.05

1.1

1.82

1.76

u/ml

0.04

265

2079

Autoimmune diseases excluding thyroid diseases, strict definition

1167

7174

0.88

4.05

1.1

1.48

2.17

u/ml

2.02

641

3717

Exclusions for E4_PCOS_CONSORTIUM

882

6325

0.87

4.04

1.1

1.62

2.05

u/ml

0.81

412

3267

Non-rheumatic valve diseases

225

2110

0.76

4.03

1.1

0.97

1.46

u/ml

0.74

121

1093

Occupational exposure to risk-factors

176

2.08

4.03

1.2

1.1

0.32

1.32

u/ml

1.65

Bacterial Sepsis

223

2421

0.76

4.02

1.1

1.65

1.54

u/ml

0.07

127

1273

Implicit Sepsis, including avohilmo

708

5898

0.85

4.02

1.1

1.87

1.69

u/ml

0.23

370

3032

Autoimmune diseases excluding thyroid diseases

1195

7302

0.88

3.99

1.1

1.46

2.15

u/ml

2.09

656

3775

Dental operations

584

2513

1.20

3.98

1.1

1.14

1.37

u/ml

0.51

297

1202

Use of anticholinesterases

457

0.47

3.98

1.1

0.18

0.42

u/ml

0.79

254

N06DA Anticholinesterases

457

0.47

3.98

1.1

0.18

0.42

u/ml

0.79

254

Other and specified injuries of hip and thigh

118

2.33

3.97

1.1

0.66

2.64

u/ml

1.17

Injuries to the neck

329

2630

1.26

3.92

1.1

2.32

1.98

u/ml

0.25

172

1345

Insulin, fast-acting

269

3426

0.78

3.92

1.1

1.33

1.91

u/ml

0.74

144

1821

Single spontaneous delivery

365

2388

0.80

3.91

1.1

1.48

2.04

u/ml

0.94

199

1246

Other viral diseases

494

4107

1.20

3.89

1.1

1.78

2.47

u/ml

0.90

264

2261

Substance use, excluding alcohol

167

2266

0.73

3.89

1.1

2.49

1.95

u/ml

0.29

1149

Benign lipomatous neoplasm

254

1968

1.30

3.89

1.0

1.1

1.45

1.28

u/ml

0.09

131

982

Endometriosis of ovary

200

1411

1.34

3.88

1.1

0.70

1.60

u/ml

2.81

711

Disorders of orbit

300

1.79

3.86

1.1

0.79

1.84

u/ml

1.01

153

Cervical disc disorders

296

2341

1.27

3.84

1.1

1.86

1.29

u/ml

0.42

151

1072

Other enthesopathy of foot (+metatarsalgia)

121

836

1.46

3.84

1.1

1.47

1.67

u/ml

0.12

396

Secondary uncertain malignant neoplasm

567

0.47

3.84

1.1

0.92

1.30

u/ml

0.24

291

Cerebrovascular diseases (FINNGEN)

231

2104

0.77

3.84

1.1

1.20

1.41

u/ml

0.21

107

1002

Lateral epicondylitis

148

1062

1.40

3.81

1.2

1.1

0.67

1.43

u/ml

1.72

493

Benign neoplasm: Colon

331

2488

1.25

3.80

1.1

1.04

1.01

u/ml

0.03

178

1208

Mycoses

304

2417

1.26

3.80

1.1

1.41

1.75

u/ml

0.32

157

1230

Endometriosis of rectovaginal septum and vagina

547

1.57

3.79

1.1

0.77

1.23

u/ml

0.64

257

Insulin, fast-acting or short human

269

3411

0.79

3.79

1.1

1.33

1.93

u/ml

0.77

144

1815

Coronary artery bypass grafting

461

0.50

3.79

1.0

1.1

1.13

0.71

u/ml

0.19

233

Xerosis cutis

2.77

3.78

1.1

1.0

0.72

0.92

u/ml

—

Iron deficiency

487

1.61

3.78

1.1

0.56

2.09

u/ml

2.98

248

Liquid cancers

116

1576

0.69

3.77

1.1

1.88

1.31

u/ml

0.29

805

Polyp of the female genital tract

308

1376

1.27

3.77

1.1

1.68

1.36

u/ml

0.23

148

679

Mental and behavioural disorders due to opioids

491

0.44

3.77

1.0

1.1

0.52

1.67

u/ml

3.00

258

Congenital malformations, deformations and chromosomal abnormalities

930

7741

1.14

3.77

1.1

2.08

2.09

u/ml

0.02

502

3995

Other neurological diseases

447

4175

0.83

3.77

1.1

1.47

1.49

u/ml

0.01

249

2102

Deep bite

244

1660

1.30

3.76

1.1

2.67

3.09

u/ml

0.21

143

1017

Polyarthropathies

627

4718

0.85

3.76

1.1

1.01

1.91

u/ml

4.21

319

2356

Other specified disorders of external ear

147

2.13

3.76

1.0

1.1

4.36

1.24

u/ml

0.62

Abrasion of teeth

393

3218

1.23

3.75

1.1

0.84

1.45

u/ml

2.04

198

1545

Lichen ruber planus, wide definition including periferal and oral lichen planus

185

1379

1.35

3.75

1.1

1.28

1.27

u/ml

0.00

669

Other and unspecified mental retardation

409

0.40

3.74

1.1

1.2

0.14

2.84

u/ml

6.88

309

Abnormal findings in secretions and smears from cervix uteri vagina vulva

768

4893

1.16

3.72

1.1

1.53

1.64

u/ml

0.12

348

2363

ILD medications: immunosuppressive drugs

733

5736

1.16

3.71

1.1

2.45

1.85

u/ml

0.81

403

2762

204

1548

1.33

3.70

1.1

2.30

2.00

u/ml

0.18

119

755

Other and unspecified visual disturbances

109

744

1.48

3.69

1.2

1.1

1.23

1.49

u/ml

0.21

372

Other/unspecified enthesopathies of lower limb, excluding foot

607

1.53

3.69

1.1

1.10

1.48

u/ml

0.28

277

Disorders of choroid and retina

520

4320

0.84

3.68

1.1

0.87

1.37

u/ml

1.65

255

2130

Type 1 diabetes, wide definition

211

2740

0.76

3.66

1.1

1.68

2.17

u/ml

0.41

122

1483

All influenza (not pneumonia)

191

1438

1.34

3.65

1.1

3.00

1.78

u/ml

0.51

103

774

Umbilical hernia

268

2111

1.27

3.64

1.1

2.15

1.27

u/ml

0.82

148

1059

Chondropathies

201

1526

1.33

3.63

1.1

2.51

1.81

u/ml

0.33

109

774

malignant neoplasm of female genital organs, including Hilmo

885

0.60

3.63

1.0

1.1

1.41

1.12

u/ml

0.13

432

Impetigo

668

1.51

3.62

1.3

1.1

4.18

2.03

u/ml

0.95

394

Other local infections of skin and subcutaneous tissue

119

830

1.44

3.62

1.1

1.31

1.63

u/ml

0.32

430

Oxycodone

160

1851

0.74

3.62

1.1

0.58

1.17

u/ml

2.16

915

Complications predominantly related to the puerperium

398

3280

1.22

3.61

1.1

2.41

1.58

u/ml

0.71

201

1594

Combinations of oral blood glucose lowering drugs

1401

0.68

3.60

1.1

1.84

1.12

u/ml

0.31

683

Other complications of surgical and medical care, not elsewhere classified

111

765

1.46

3.60

1.2

1.1

1.11

1.87

u/ml

0.79

374

Other viral hepatitis, including avohilmo

771

0.56

3.59

1.1

0.45

1.92

u/ml

4.24

386

Other spirochaetal diseases, including avohilmo

348

2829

1.23

3.58

1.1

1.37

1.62

u/ml

0.26

174

1445

Fall on same level involving ice and snow

655

5632

1.17

3.58

1.1

1.73

1.78

u/ml

0.05

343

2856

MS-disease / Multiple Sclerosis

809

0.57

3.58

1.0

1.1

1.22

1.43

u/ml

0.08

406

Immunodeficiency with predominantly antibody defects

235

1.87

3.56

1.1

3.11

2.08

u/ml

0.22

134

Postmenopausal bleeding

159

601

1.39

3.55

1.1

1.30

0.65

u/ml

0.50

285

Hypothyroidism (congenital or acquired)

514

2415

1.20

3.54

1.1

1.77

2.35

u/ml

0.62

250

1207

Use of disulfiram, acamprosate or naltrexone

756

0.56

3.53

1.1

0.47

1.73

u/ml

3.14

360

Other and unspecified disorders of vitreous body

277

2148

1.26

3.53

1.1

1.04

u/ml

0.00

138

1007

Other specified/unspecified bacterial intestinal infections

392

1.65

3.53

1.1

0.58

1.70

u/ml

1.89

208

Mental and behavioural disorders due to use of other stimulants, including caffeine

421

0.42

3.52

1.1

7.37

1.74

u/ml

0.43

219

Persons encountering health services in circumstances related to reproduction

875

5142

1.14

3.52

1.1

2.42

2.23

u/ml

0.21

461

2707

Major coronary heart disease event excluding revascularizations

236

1996

0.78

3.51

1.1

1.15

1.03

u/ml

0.15

116

999

Kidney transplant status

477

0.46

3.50

1.0

1.1

0.55

1.47

u/ml

2.53

278

Polyneuropathies and other disorders of the peripheral nervous system

146

1062

1.38

3.48

1.2

1.1

1.42

1.21

u/ml

0.12

528

Gluteal tendinitis

258

1.80

3.48

1.1

0.69

1.57

u/ml

0.72

119

Other spirochaetal diseases

340

2767

1.23

3.48

1.1

1.40

1.62

u/ml

0.21

168

1412

Primary_lymphoid and hematopoietic malignant neoplasms

1211

0.66

3.48

1.1

2.11

1.34

u/ml

0.28

647

Mild mental retardation

361

0.38

3.46

1.3

1.2

5.01

2.54

u/ml

—

235

Atypical facial pain

356

1.68

3.46

1.1

0.69

1.59

u/ml

1.38

183

Acute lymphadenitis

658

1.49

3.46

1.1

1.17

1.81

u/ml

0.49

346

Benign neoplasm: Choroid

281

1.76

3.43

1.0

1.1

1.44

1.10

u/ml

0.14

141

Olecranon bursitis

281

1.76

3.43

1.0

1.1

2.06

1.35

u/ml

0.31

135

Suppurative otitis media, unspecified

260

1.80

3.43

1.1

1.60

1.76

u/ml

0.10

153

Type 1 diabetes, strict (exclude DM2)

118

1644

0.71

3.41

1.1

1.99

2.50

u/ml

0.26

946

Complications of procedures, not elsewhere classified

934

6645

1.13

3.41

1.1

1.64

1.63

u/ml

0.01

483

3256

Type 1 diabetes, wide definition, subgroup 1

206

2655

0.77

3.40

1.1

1.49

2.19

u/ml

0.72

117

1432

Heart failure and coronary heart disease

104

1048

0.69

3.38

1.1

0.96

0.80

u/ml

0.14

555

malignant neoplasm of male genital organs

709

0.65

3.38

1.0

1.1

0.65

0.89

u/ml

0.38

358

Implicit viral Sepsis, including avohilmo

282

2251

1.25

3.38

1.1

2.28

1.66

u/ml

0.51

162

1176

Oter anti-inflammatory and antirheumatic agents, non-steroids

122

467

1.44

3.37

1.1

1.07

1.52

u/ml

0.22

237

Bacterial pneumonia (organism specified)

375

2796

1.22

3.37

1.1

1.83

1.57

u/ml

0.26

229

1419

Obsessive-compulsive disorder

154

1141

1.37

3.35

1.1

2.41

2.38

u/ml

0.02

606

Viral hepatitis, including avohilmo

831

0.60

3.35

1.1

0.44

1.84

u/ml

4.41

419

Other diseases of liver

186

1415

1.32

3.34

1.1

2.06

1.55

u/ml

0.22

701

Bacterial infection, other or unspecified

307

3189

0.81

3.32

1.1

1.84

1.39

u/ml

0.47

169

1656

Ulcer of vagina/vulva

278

1.76

3.31

1.1

0.62

1.89

u/ml

2.31

140

Other systemic involvement of connective tissue

240

1890

1.27

3.30

1.1

0.75

1.47

u/ml

2.23

126

939

Other diseases of anus and rectum

249

1964

1.27

3.27

1.1

1.58

1.46

u/ml

0.11

122

1001

Malignant neoplasm of respiratory system and intrathoracic organs

531

0.54

3.26

1.0

1.1

0.46

1.01

u/ml

0.60

266

Pain, not elsewhere classified

343

2816

1.22

3.26

1.1

1.48

1.93

u/ml

0.55

195

1429

Coeliac disease

154

1145

1.35

3.26

1.1

1.53

1.92

u/ml

0.28

611

Hard cardiovascular diseases

670

4562

0.87

3.26

1.1

1.51

1.54

u/ml

0.03

321

2312

Rheumatism, unspecified

112

789

1.43

3.25

1.1

1.27

1.46

u/ml

0.09

370

Other diseases of stomach and duodenum

271

1.75

3.25

1.2

1.1

3.66

1.32

u/ml

0.54

143

Budesonide

160

1197

1.34

3.24

1.1

1.77

1.34

u/ml

0.30

557

Otitis media, unspecified

248

1814

1.27

3.22

1.2

1.1

2.70

3.01

u/ml

0.18

161

1060

Type 1 diabetes, definitions combined

120

1649

0.72

3.22

1.1

2.35

2.46

u/ml

0.04

947

Hypothyroidism and >3 levothyroxin purchases

506

2400

1.19

3.21

1.1

1.80

2.37

u/ml

0.60

247

1195

Hypothyroidism, levothyroxine purchases

506

2400

1.19

3.21

1.1

1.80

2.37

u/ml

0.60

247

1195

Flat foot [pes planus] (acquired)

684

1.46

3.21

1.1

1.57

1.59

u/ml

0.01

340

Implicit fungal Sepsis, including avohilmo

379

1.62

3.21

1.1

1.82

1.71

u/ml

0.05

197

Lyme disease

332

2722

1.22

3.20

1.1

1.40

1.57

u/ml

0.15

167

1376

Lyme disease, including avohilmo

332

2722

1.22

3.20

1.1

1.40

1.57

u/ml

0.15

167

1376

Viral infections characterized by skin and mucous membrane lesions

508

4326

1.18

3.20

1.1

2.65

1.97

u/ml

0.64

284

2314

Polyuria

162

1216

1.34

3.19

1.1

0.58

1.23

u/ml

1.98

600

Carpal tunnel syndrome

616

4610

1.16

3.18

1.1

1.43

1.33

u/ml

0.13

289

2186

Metabolic disorders

918

6204

0.89

3.18

1.1

1.39

1.76

u/ml

0.89

530

3068

Other systemic involvement of connective tissue (FG)

237

1839

1.27

3.17

1.1

0.76

1.36

u/ml

1.65

123

910

Stenosis and insufficiency of lacrimal passages

547

1.51

3.17

1.1

1.79

1.48

u/ml

0.16

276

Cervical polyps

588

1.49

3.15

1.0

1.1

2.56

0.92

u/ml

0.71

278

Continuous positive airway pressure

196

1258

1.30

3.15

1.1

0.97

2.12

u/ml

2.49

112

673

Benign neoplasm: Liver

187

1.90

3.14

1.1

0.31

1.54

u/ml

1.93

Complications associated with artificial fertilization

224

1.83

3.12

1.0

1.1

2.03

1.23

u/ml

0.37

106

Unspecified event, undetermined intent

231

1.81

3.12

1.3

1.1

2.12

1.89

u/ml

0.07

123

Thyroiditis, ILD-related definition

156

1171

1.34

3.12

1.1

1.58

1.69

u/ml

0.06

578

Severe mental retardation

0.00

3.12

0.0

1.2

—

2.47

—

Benign neoplasm: Liver/bile ducts

209

1.85

3.12

1.1

0.29

1.38

u/ml

2.01

109

Other symptoms and signs involving the digestive system and abdomen

167

1265

1.33

3.11

1.1

0.90

1.54

u/ml

1.02

665

Pre-eclampsia or poor fetal growth

360

4303

0.83

3.11

1.1

1.59

1.72

u/ml

0.11

170

2077

Localized swelling, mass and lump of skin and subcutaneous tissue

334

2751

1.22

3.09

1.1

1.20

1.58

u/ml

0.52

171

1412

Disorders of eyelid in diseases classified elsewhere

217

1.82

3.08

1.2

1.1

5.92

2.01

u/ml

0.73

116

Examination and encounter for administrative purposes

352

1.63

3.08

1.1

0.63

1.58

u/ml

1.55

136

L04AA Selective immunosuppressants

165

2159

0.76

3.07

1.1

1.32

1.75

u/ml

0.51

1108

Thyroiditis

601

1.48

3.06

1.1

3.15

1.37

u/ml

0.67

302

Alzheimer disease, excluding more controls

234

0.41

3.06

1.1

1.0

0.25

0.60

u/ml

—

131

Melanocytic naevi of eyelid, including canthus

2.96

3.06

1.2

1.0

4.55

1.01

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

131

960

1.37

3.05

1.0

1.1

0.90

1.42

u/ml

0.80

463

Patellar tendinitis

175

1.93

3.05

1.0

1.1

4.00

2.94

u/ml

0.20

Melanocytic naevi

391

3278

1.20

3.02

1.1

2.05

1.74

u/ml

0.29

207

1662

Other and unspecified local infections of skin and subcutaneous tissue

112

802

1.41

3.01

1.1

1.34

1.67

u/ml

0.31

414

Injury of muscle and tendon at lower leg level

150

1125

1.34

3.01

1.1

1.53

1.62

u/ml

0.04

558

Emotional disorders starting during childhood or adolecense, excluding more controls

137

986

1.37

3.01

1.1

1.98

2.95

u/ml

0.56

603

COPD, hospital admissions 3, with asthma pneumonia sepsis

108

655

1.42

3.00

1.1

1.18

0.97

u/ml

0.20

336

Other sleep disorders

122

887

1.38

3.00

1.1

2.84

1.65

u/ml

0.72

442

Spirochaetal infections, other/unspecified, including avohilmo

333

2752

1.21

2.99

1.1

1.40

1.63

u/ml

0.22

167

1396

Unspecified fall

574

4874

1.16

2.99

1.1

1.86

2.18

u/ml

0.26

332

2622

Impingement syndrome of shoulder

175

1343

1.31

2.98

1.0

1.1

0.50

1.15

u/ml

2.47

633

Retained placenta and membranes, without haemorrhage

149

1120

1.34

2.97

1.1

0.70

1.46

u/ml

1.80

526

Influenza and pneumonia

1463

8226

1.10

2.96

1.1

2.06

1.96

u/ml

0.15

836

4153

Type 1 diabetes, strict definition

110

1508

0.72

2.95

1.1

2.49

2.46

u/ml

0.01

875

Other viral hepatitis

715

0.60

2.94

1.1

0.45

1.83

u/ml

3.61

348

Benign neoplasm of other and ill-defined parts of digestive system

123

898

1.38

2.94

1.2

1.1

0.60

1.38

u/ml

1.90

435

Fall on and from stairs and steps

272

2208

1.24

2.93

1.1

1.82

1.75

u/ml

0.04

154

1144

Malignant neoplasm of bronchus and lung

419

0.52

2.92

1.0

1.1

0.56

1.05

u/ml

0.39

211

Obesity due to excess calories

646

5652

1.15

2.91

1.1

1.58

1.87

u/ml

0.43

352

2807

malignant neoplasm of female genital organs

760

0.61

2.90

1.0

1.1

1.59

1.12

u/ml

0.20

362

Demyelinating diseases of the central nervous system

920

0.65

2.88

1.0

1.1

0.90

1.34

u/ml

0.28

453

Oral lichen planus, including avohilmo , including avohilmo

391

1.57

2.86

1.0

1.1

0.36

1.38

u/ml

1.89

193

Endometriosis ASRM stages 1,2

255

2064

1.24

2.86

1.1

0.71

1.53

u/ml

2.91

109

1004

Viral hepatitis

771

0.62

2.85

1.1

0.44

1.80

u/ml

3.95

381

Metatarsalgia

106

760

1.40

2.85

1.1

1.54

1.65

u/ml

0.06

356

Impacted teeth

480

3533

1.17

2.84

1.1

2.43

2.66

u/ml

0.13

274

1933

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

518

4420

1.16

2.84

1.1

1.86

2.15

u/ml

0.36

306

2352

Other disorders of conjunctiva

610

1.45

2.83

1.1

2.87

1.39

u/ml

0.77

305

Subacute thyroiditis

276

1.69

2.83

1.0

1.1

2.27

1.06

u/ml

0.24

136

Status post-ami

522

0.59

2.82

1.0

0.96

0.69

u/ml

0.16

262

Chronic periodontitis, complicated

340

3962

0.83

2.82

1.1

1.08

1.26

u/ml

0.26

196

1900

Haemorrhoids and perianal venous thrombosis

274

2219

1.23

2.81

1.1

1.46

1.42

u/ml

0.03

119

1110

Haemangioma and lymphangioma, any site

107

771

1.40

2.81

1.1

0.86

1.63

u/ml

1.67

408

161

1106

1.31

2.81

1.1

0.65

0.78

u/ml

0.13

563

ILD-related respiratory insufficiency

2.41

2.80

1.1

3.85

1.39

u/ml

—

Malignant neoplasm of skin, including Hilmo

265

2179

0.81

2.79

1.1

0.52

1.05

u/ml

2.07

135

1041

Bacterial infection, other or unspecified, including avohilmo

385

3732

0.84

2.79

1.1

1.60

1.57

u/ml

0.03

221

1931

Cardiovascular diseases

1253

6033

1.10

2.79

1.1

2.07

2.30

u/ml

0.32

670

3162

Other puerperal infections

162

1248

1.31

2.78

1.1

4.04

1.44

u/ml

1.48

606

Type 1 diabetes, strict definition, subgroup 1

105

1434

0.72

2.77

1.1

2.17

2.53

u/ml

0.16

833

Pneumonia due to other infectious organisms, not elsewhere classified

159

1.91

2.77

1.2

1.0

4.34

1.46

u/ml

0.34

Other acute skin changes due to ultraviolet radiation

159

1.91

2.77

1.2

1.0

0.41

1.24

u/ml

1.17

Hypertensive diseases

823

5216

0.89

2.77

1.1

1.38

1.60

u/ml

0.38

432

2532

Other demyelinating diseases of the central nervous system

421

0.49

2.76

1.0

1.1

0.20

1.60

u/ml

4.46

200

Bleeding

622

4978

0.87

2.76

1.1

2.50

1.63

u/ml

0.82

334

2568

Acne

256

2074

1.24

2.75

1.1

2.83

2.94

u/ml

0.05

165

1155

Diagnoses used for exclusion with ILD

184

1439

1.28

2.75

1.1

1.67

1.48

u/ml

0.08

711

Pain associated with micturition

121

893

1.36

2.74

1.1

1.97

1.78

u/ml

0.09

469

Other and unspecified nerve root and plexus disorders, also in other diseases

216

1724

1.26

2.74

1.1

2.10

1.44

u/ml

0.34

109

843

Disorders of ocular muscles, binocular movement, accommodation and refraction

704

6167

1.13

2.74

1.1

1.93

2.18

u/ml

0.32

376

3260

Benign neoplasm: Duodenum

2.39

2.73

1.5

1.1

0.62

0.45

u/ml

—

Suicide or other Intentional self-harm

231

2856

0.81

2.73

1.1

1.52

2.04

u/ml

0.53

134

1459

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

383

3242

1.19

2.72

1.1

2.69

2.12

u/ml

0.37

192

1666

Delivery

387

2413

0.84

2.70

1.1

1.47

2.07

u/ml

1.07

211

1262

Hypertension

823

5205

0.89

2.69

1.1

1.38

1.60

u/ml

0.38

432

2527

Other skin changes

157

1207

1.31

2.69

1.1

2.92

1.35

u/ml

0.91

607

Oral lichen planus

112

2.08

2.68

1.0

1.1

0.15

0.77

u/ml

1.31

malignant neoplasm of male genital organs, including Hilmo

742

0.70

2.68

1.0

1.1

0.68

0.87

u/ml

0.31

375

Colonic or urogenital fistula

264

2160

1.23

2.67

1.1

2.02

1.43

u/ml

0.36

122

1082

Persistent delusional disorders

483

0.53

2.67

1.1

0.30

1.27

u/ml

3.32

233

Haemangioma, any site

686

1.41

2.66

1.1

0.77

1.67

u/ml

1.97

363

Delirium, not induced by alcohol and other psychoactive substances

336

0.44

2.66

1.0

1.1

0.04

1.17

u/ml

—

171

Separation of retinal layers (serosa)

258

1.68

2.65

1.1

0.50

1.61

u/ml

2.19

124

Idiopathic pulmonary fibrosis

154

1.89

2.65

1.1

1.35

0.93

u/ml

0.16

Other and unspecified disorders of autonomic nervous system

3.48

2.65

1.1

0.20

0.19

u/ml

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

646

0.63

2.65

1.1

0.57

1.01

u/ml

0.61

332

Open wound of wrist and hand

581

4911

1.15

2.64

1.1

2.49

1.76

u/ml

0.84

298

2522

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

441

0.52

2.62

1.2

1.1

3.40

1.57

u/ml

0.32

229

258

1.67

2.61

1.0

1.1

2.95

1.94

u/ml

0.23

120

Hernia of abdominal wall

395

3362

1.18

2.61

1.1

2.02

1.35

u/ml

0.77

206

1668

Benign lipomatous neoplasm of other sites/unspecified

345

1.57

2.59

1.0

1.1

0.56

1.27

u/ml

1.02

177

Secondary and unspecified malignant neoplasm of lymph nodes

413

0.51

2.59

1.1

1.02

1.26

u/ml

—

215

Contraceptive management

604

3701

1.14

2.58

1.1

1.94

1.98

u/ml

0.04

297

1813

Urethritis and urethral syndrome

135

1.95

2.57

1.3

1.1

1.33

2.17

u/ml

0.29

Coronary atherosclerosis

298

2261

0.83

2.57

1.1

1.40

1.13

u/ml

0.36

144

1103

Sequelae of cerebrovascular disease

103

1199

0.73

2.56

1.0

1.1

0.98

0.91

u/ml

0.05

589

Other abnormal products of conception

606

3488

1.14

2.56

1.1

2.31

1.77

u/ml

0.62

282

1670

Benign neoplasm of eye and adnexa

574

1.44

2.55

1.0

1.1

1.67

1.60

u/ml

0.03

297

Heart failure and antihypertensive medication

118

1025

0.75

2.54

1.1

0.91

1.49

u/ml

0.75

516

Other disorders of penis

106

776

1.37

2.54

1.1

1.63

2.75

u/ml

0.75

471

Systemic connective tissue disorders

299

2491

1.20

2.53

1.1

0.67

1.41

u/ml

3.26

161

1243

severe traumatic brain injury, does not include concussion

1049

0.69

2.53

1.1

1.06

1.32

u/ml

0.30

540

Other and unspecified trigeminal disorders

2.20

2.53

1.1

1.90

1.10

u/ml

—

Lichen planus, including avohilmo

147

1131

1.30

2.53

1.1

1.48

1.28

u/ml

0.12

544

Other maternal disorders predominantly related to pregnancy

833

4663

1.12

2.52

1.1

1.44

1.87

u/ml

0.97

397

2260

Melanoma in situ

143

1.90

2.51

1.0

0.62

1.75

u/ml

0.90

Other/unspecified synovitis and tenosynovitis

116

864

1.35

2.51

1.1

1.01

1.57

u/ml

0.60

403

False labour

593

3227

1.15

2.51

1.1

1.61

2.03

u/ml

0.62

283

1589

Atrial septal defect

592

0.59

2.51

1.0

1.2

2.64

3.17

u/ml

0.11

409

Crushed, pushed or stepped on by crowd or human stampede

140

1074

1.32

2.51

1.1

3.71

2.18

u/ml

0.52

581

Alzheimer’s disease, strict definition

288

0.48

2.50

1.1

1.0

0.11

0.30

u/ml

1.32

158

Hypothyroidism, strict autoimmune, 3 medication purchases required

1015

6169

1.11

2.50

1.1

1.43

1.71

u/ml

0.50

463

3114

Disorders of vestibular function (Vertigo)

370

3062

1.18

2.49

1.1

1.40

1.16

u/ml

0.27

192

1490

Caries of dentine, including avohilmo

905

4152

1.12

2.49

1.1

1.67

1.87

u/ml

0.31

497

2044

Erysipelas

332

3387

0.84

2.47

1.1

1.87

1.21

u/ml

1.23

203

1652

Other gastritis (incl. Duodenitis)

150

1161

1.30

2.47

1.1

1.40

1.30

u/ml

0.10

552

Chronic viral hepatitis

607

0.60

2.46

1.1

0.50

1.68

u/ml

3.35

297

Acute alcohol intoxication

173

2178

0.79

2.44

1.1

2.71

1.78

u/ml

0.56

1097

Other factor of the environment

2.21

2.44

1.2

1.0

0.34

1.49

u/ml

1.16

Other disorders starting during childhood or adolecense, excluding more controls

142

1047

1.31

2.43

1.1

3.21

2.70

u/ml

0.22

645

Peroneal tendinitis

131

1.94

2.43

1.0

1.1

3.47

1.61

u/ml

0.27

Pericarditis

174

1.80

2.43

1.3

1.1

0.99

1.79

u/ml

0.51

Postpartum care and examination

217

1674

0.81

2.42

1.1

3.89

2.34

u/ml

0.84

812

Other bursopathies

724

1.37

2.41

1.1

1.96

1.45

u/ml

0.22

340

Gingivitis and periodontal diseases

1207

5688

1.10

2.41

1.1

1.57

1.83

u/ml

0.59

637

2864

Obesity, other/unspecified

454

3937

1.16

2.40

1.1

1.42

1.74

u/ml

0.43

266

1929

Other epidermal thickening

297

1.60

2.40

1.1

0.95

1.43

u/ml

0.57

155

Abscess of external ear

2.10

2.40

1.0

1.1

3.64

1.27

u/ml

0.30

Malignant neoplasm of bronchus and lung, including Hilmo

506

0.61

2.39

1.1

0.62

0.90

u/ml

0.28

252

Concussion

724

5006

1.12

2.39

1.1

1.81

2.28

u/ml

0.72

403

2626

Female infertility, tubal origin

442

1.48

2.39

1.1

0.98

1.11

u/ml

0.10

209

Bacterial intestinal infections, IBD co-morbidities

146

1132

1.29

2.39

1.1

0.95

1.42

u/ml

0.66

574

Endocrine, nutritional and metabolic diseases

1318

6099

1.09

2.39

1.1

1.78

2.28

u/ml

1.25

720

3123

Contracture of joint

2.45

2.39

1.0

1.1

1.76

2.55

u/ml

—

Other congenital malformations of skin, including avohilmo

119

899

1.33

2.38

1.1

0.79

2.06

u/ml

3.29

477

Fibroblastic disorders

151

1176

1.29

2.38

1.1

1.43

1.30

u/ml

0.07

557

Mental and behavioural disorders due to cannabinoids

462

0.55

2.37

1.2

1.1

0.76

1.85

u/ml

1.67

245

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

170

2133

0.79

2.37

1.1

1.77

2.05

u/ml

0.16

1090

Retinal breaks without detachment

112

838

1.34

2.36

1.1

0.71

1.26

u/ml

1.03

400

Other/unspecified soft tissue disorders related to use, overuse and pressure

221

1.69

2.36

1.1

1.0

0.31

2.37

u/ml

2.75

111

Ill-defined and unknown causes of mortality

264

0.42

2.35

1.0

1.1

0.69

1.38

u/ml

—

142

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1015

7513

0.91

2.34

1.1

1.79

u/ml

0.01

563

3804

Ischemic heart diseases

626

4205

0.88

2.34

1.1

1.51

1.55

u/ml

0.05

285

2140

Zoster [herpes zoster], including avohilmo

443

3705

1.16

2.34

1.1

1.78

1.45

u/ml

0.38

235

1838

Diseases of arteries, arterioles and capillaries (FINNGEN)

133

1189

0.77

2.33

1.1

0.68

1.21

u/ml

1.18

576

Implicit bacterial Sepsis

178

1906

0.80

2.33

1.1

1.51

1.35

u/ml

0.09

102

983

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

396

1.50

2.32

1.0

1.1

0.82

1.88

u/ml

1.46

190

Bicipital tendinitis

245

1.65

2.32

1.1

0.20

2.17

u/ml

2.91

115

Other disorders of cornea

620

1.39

2.31

1.1

4.82

1.48

u/ml

1.56

298

Sacrococcygeal disorders, not elsewhere classified

238

1.66

2.31

1.2

1.1

0.17

1.85

u/ml

3.73

116

Pedestrian injured in collision with pedal cycle

215

1.69

2.30

1.1

0.36

1.59

u/ml

2.41

114

Hypertensive heart and/or renal disease

686

0.69

2.30

1.0

1.1

0.16

0.92

u/ml

3.77

344

Antihypertensive medication - note that there are other indications

1203

5752

1.10

2.30

1.1

1.87

2.34

u/ml

1.07

622

3046

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

167

1324

1.27

2.30

1.1

2.69

1.54

u/ml

0.74

712

Other bacterial intestinal infections

145

1130

1.29

2.30

1.1

1.00

1.46

u/ml

0.60

581

Persons encountering health services for specific procedures, not carried out

112

844

1.34

2.29

1.1

0.87

1.95

u/ml

1.95

405

Medial epicondylitis

254

1.63

2.28

1.2

1.1

0.18

1.79

u/ml

3.10

119

Other and unspecified injuries of ankle and foot

522

1.43

2.28

1.1

0.74

1.90

u/ml

2.09

276

Noninfectious colitis NAS

158

1247

1.27

2.28

1.1

1.80

1.70

u/ml

0.04

656

Autoimmune thyroiditis

186

1.75

2.28

1.1

4.85

1.32

u/ml

0.68

192

1553

1.25

2.27

1.1

1.73

1.64

u/ml

0.05

122

736

Other/unspecified disorders of vestibular function

193

1.72

2.27

1.1

1.0

0.48

1.77

u/ml

1.78

Sequelae of other external causes

390

1.50

2.26

1.2

1.1

1.97

1.47

u/ml

0.13

200

Seborrhoeic keratosis

151

1185

1.28

2.26

1.1

0.58

1.01

u/ml

0.80

567

Infections with a predominantly sexual mode of transmission

503

4406

1.14

2.26

1.1

1.67

1.95

u/ml

0.24

250

2218

Disorders of lipoprotein metabolism and other lipidaemias

623

4264

0.89

2.26

1.1

1.23

1.33

u/ml

0.14

363

2016

Disorders of refraction and accommodation

441

3822

1.15

2.26

1.1

2.07

2.25

u/ml

0.15

232

2093

Disorders of gallbladder, biliary tract and pancreas

886

6086

0.90

2.26

1.1

1.05

1.55

u/ml

1.89

429

2969

Malignant neoplasm of brain, including Hilmo

326

0.49

2.24

1.3

1.1

4.69

1.60

u/ml

—

175

Inflammatory disorders of breast

104

779

1.35

2.23

1.1

2.47

1.65

u/ml

0.25

383

Sequelae of injuries, of poisoning and of other consequences of external causes

253

2105

1.21

2.23

1.1

1.07

1.66

u/ml

1.24

133

1060

Achilles tendinitis

709

1.36

2.23

1.1

3.48

1.43

u/ml

0.84

320

Myocardial infarction, strict

157

1403

0.79

2.23

1.1

0.84

0.91

u/ml

0.08

699

Type1 diabetes, definitions combined, early onset

1310

0.74

2.23

1.1

2.39

2.53

u/ml

0.05

785

Amputation

298

0.47

2.21

1.1

0.37

1.21

u/ml

—

156

Other erythematous conditions

210

1.68

2.21

1.1

0.59

1.77

u/ml

1.51

104

Implicit bacterial Sepsis, including avohilmo

215

2176

0.82

2.21

1.1

1.43

1.32

u/ml

0.08

120

1123

Malignant neoplasm of skin

243

1981

0.83

2.20

1.1

0.54

1.05

u/ml

1.75

127

952

Anogenital herpesviral [herpes simplex] infection, including avohilmo

205

1676

1.23

2.20

1.1

1.19

1.90

u/ml

1.15

855

Disorders of lacrimal system and orbit in diseases classified elsewhere

158

1.79

2.19

1.0

1.1

0.58

1.34

u/ml

0.63

Lichen planus

652

1.37

2.18

1.1

1.75

1.33

u/ml

0.17

322

Other predominantly sexually transmitted diseases, not elsewhere classified

285

2406

1.19

2.17

1.1

2.18

1.90

u/ml

0.14

143

1226

Neuralgia and neuritis, unspecified

345

1.52

2.17

1.1

1.45

1.98

u/ml

0.28

165

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

196

1.70

2.16

1.1

0.16

2.17

u/ml

2.40

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.20

2.16

1.3

1.0

0.31

1.82

u/ml

—

Maternal care for other known or suspected fetal problems

396

2866

0.86

2.16

1.1

2.34

1.94

u/ml

0.32

190

1428

Lymphoid leukaemia

281

0.46

2.16

1.2

0.19

1.61

u/ml

—

181

Acute alcohol intoxication, ICD10

155

1942

0.79

2.15

1.1

2.83

1.89

u/ml

0.51

999

Coxarthrosis [arthrosis of hip](FG)

280

2285

0.84

2.15

1.1

1.02

1.11

u/ml

0.08

130

1080

Other noninflammatory disorders of vagina

621

1.38

2.14

1.0

1.1

0.58

1.09

u/ml

1.32

300

Acute nasopharyngitis (common cold)

136

1055

1.29

2.13

1.1

2.45

1.39

u/ml

0.58

538

Non-selective monoamine reuptake inhibitors

278

2247

1.19

2.13

1.1

0.60

1.26

u/ml

3.20

164

1029

Macular cyst

2.11

2.13

1.0

0.26

0.83

u/ml

0.69

Use of pramipexole

144

1134

1.27

2.12

1.1

1.30

1.31

u/ml

0.00

556

Panniculitis affecting regions of neck and back

228

1.64

2.12

1.1

1.53

1.54

u/ml

0.00

108

Habitual aborter

276

1.58

2.12

1.1

2.28

1.21

u/ml

0.40

128

Mental and behavioural disorders due to sedatives or hypnotics

692

0.66

2.12

1.1

1.66

1.74

u/ml

0.05

356

Diseases of tongue

339

1.51

2.11

1.1

3.04

1.59

u/ml

0.50

146

Acute generalized exanthematous pustulosis

356

1.50

2.11

1.0

1.1

3.78

1.86

u/ml

0.35

190

Focal epilepsy

156

1946

0.80

2.10

1.1

3.17

2.08

u/ml

0.38

1083

Abnormal findings on diagnostic imaging of breast

2.17

2.10

1.1

1.0

0.32

0.80

u/ml

—

Superficial injury of thorax

149

1181

1.27

2.10

1.1

1.55

1.42

u/ml

0.10

599

Superficial injury of wrist and hand

321

2746

1.17

2.10

1.1

1.67

2.04

u/ml

0.40

169

1493

Intentional self-harm by jumping from a high place

0.00

2.09

0.0

1.1

—

0.71

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

124

1.88

2.09

1.1

5.97

2.01

u/ml

0.47

Myocardial infarction

178

1535

0.81

2.09

1.1

1.18

0.91

u/ml

0.32

758

Diseases of inner ear

433

3621

1.15

2.07

1.1

1.36

1.30

u/ml

0.06

223

1766

Benign neoplasms

1391

7008

1.08

2.06

1.1

1.72

2.04

u/ml

0.63

722

3577

Pleural plaque

117

1.89

2.05

1.0

1.1

0.52

0.40

u/ml

0.14

conjunctival haemorrhage

301

1.54

2.05

1.0

1.1

4.29

1.17

u/ml

0.98

160

Other and unspecified hypertrophic disorders of skin

2.47

2.05

1.1

0.43

1.92

u/ml

—

Other inflammation of vagina/vulva

458

1.44

2.05

1.1

0.95

1.50

u/ml

0.60

216

Other noninflammatory disorders of vulva and perineum

117

903

1.30

2.05

1.1

2.04

1.74

u/ml

0.15

449

Insulin, fast-acting (human)

123

1572

0.78

2.05

1.1

1.23

1.85

u/ml

0.76

801

Other and unspecified erythematous conditions

192

1.68

2.04

1.1

0.35

1.69

u/ml

1.89

Disorders of vitreous body

335

2737

1.17

2.04

1.1

1.20

1.08

u/ml

0.09

167

1304

Focal epilepsy, mode (most common among epilepsy diagnosis)

129

1638

0.78

2.04

1.1

2.62

2.18

u/ml

0.13

916

Viral pneumonia (known virus, not influenza)

177

1.71

2.04

1.2

1.1

2.72

2.37

u/ml

0.05

106

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

327

0.52

2.04

1.0

1.1

0.78

1.38

u/ml

—

156

Disorders of vitreous body and globe

343

2792

1.16

2.03

1.1

1.17

1.07

u/ml

0.07

171

1336

Polycystic ovarian syndrome, consortium definition

1030

5411

1.09

2.01

1.1

1.39

1.97

u/ml

1.56

516

2652

Premenstrual syndrome

186

1.70

2.01

1.1

1.02

1.50

u/ml

0.30

Procreative management

547

4005

1.13

2.01

1.1

2.34

2.23

u/ml

0.09

321

2150

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

271

1.56

2.00

1.0

1.29

1.03

u/ml

0.16

140

Hordeolum and other deep inflammation of eyelid

587

1.37

1.99

1.1

3.70

1.74

u/ml

0.63

316

Actinic keratosis

121

854

1.29

1.99

1.1

0.76

0.79

u/ml

0.03

447

Female genital prolapse

243

1125

1.20

1.99

1.1

0.74

1.11

u/ml

0.88

116

545

Parkinson's disease, including avohilmo

377

0.56

1.99

1.0

1.1

0.43

0.84

u/ml

0.76

196

Viral pneumonia (unknown virus, not influenza)

536

1.39

1.99

1.1

2.58

1.55

u/ml

0.35

276

Polyarteritis nodosa and related conditions

2.01

1.97

1.4

1.1

0.49

0.76

u/ml

0.31

Meniscus derangement

506

2968

1.13

1.97

1.1

1.00

1.35

u/ml

0.76

249

1383

Deficiency of other B group vitamins

2.00

1.96

1.2

1.0

0.10

1.35

u/ml

—

Monoamine oxidase A inhibitors

691

1.34

1.96

1.1

0.94

1.54

u/ml

0.67

331

Atrial septal defect, secundum type

482

0.61

1.96

1.0

1.2

2.93

3.14

u/ml

0.03

337

Medicines for HER+ breast cancer

206

2309

0.83

1.95

1.1

1.67

1.03

u/ml

0.67

107

1080

Focal epilepsy, strict definition

135

1695

0.79

1.95

1.1

2.90

2.20

u/ml

0.21

957

Acute lymphocytic leukaemia

140

0.34

1.95

1.6

1.2

0.23

1.83

u/ml

—

Acute lymphocytic leukaemia, helper endpoint

140

0.34

1.95

1.6

1.2

0.23

1.83

u/ml

—

Acute lymphocytic leukaemia, including Hilmo

140

0.34

1.95

1.6

1.2

0.23

1.83

u/ml

—

Periapical abscess

405

4616

0.88

1.94

1.1

1.63

u/ml

0.00

246

2321

Poor fetal growth

167

2044

0.81

1.93

1.1

1.44

1.60

u/ml

0.13

1001

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

181

1482

1.23

1.93

1.1

2.45

1.59

u/ml

0.57

109

791

Care involving dialysis

460

0.61

1.92

1.0

1.1

0.46

1.65

u/ml

3.46

250

Spondylosis

417

2853

1.14

1.92

1.1

1.25

1.24

u/ml

0.00

203

1307

Haemorrhage in early pregnancy

400

3402

1.15

1.92

1.1

1.12

1.74

u/ml

1.28

178

1636

Generalized skin eruption due to drugs and medicaments

315

1.51

1.92

1.0

1.1

4.28

1.80

u/ml

0.41

168

Acute epiglottitis

1.99

1.92

1.2

1.0

0.09

2.39

u/ml

—

Glaucoma suspect

214

1781

1.20

1.91

1.1

1.50

1.09

u/ml

0.22

894

Viral meningitis, including avohilmo

398

1.45

1.91

1.1

1.25

2.10

u/ml

0.76

209

Benign neoplasm of colon, rectum, anus and anal canal

403

2980

1.14

1.90

1.1

1.03

1.05

u/ml

0.03

212

1431

Other or unspecified immunodeficiency

2.75

1.90

1.2

1.1

3.68

2.30

u/ml

—

Use of biperiden

319

0.53

1.90

1.0

1.1

1.58

1.30

u/ml

—

163

Benign neoplasm: Skin of ear and external auricular canal

143

1.76

1.89

1.0

0.23

1.13

u/ml

1.70

Other disorders of veins

368

3155

1.15

1.89

1.1

0.88

1.19

u/ml

0.77

168

1491

Heart failure and bmi 25plus

107

922

0.77

1.89

1.0

1.1

0.72

1.01

u/ml

0.39

446

Hypertensive Heart Disease

595

0.70

1.88

1.0

1.1

0.13

0.93

u/ml

3.53

305

Other and unspecified acute skin changes due to ultraviolet radiation

2.17

1.88

1.1

0.32

1.24

u/ml

—

Melanocytic naevi of lower limb, including hip

399

1.44

1.88

1.1

3.43

1.68

u/ml

0.42

205

Bacterial pneumonia, not elsewhere classified

327

2479

1.16

1.88

1.1

1.96

1.55

u/ml

0.42

204

1265

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.06

1.87

1.6

1.0

0.42

1.21

u/ml

0.93

Later onset COPD

331

1.43

1.87

1.0

0.20

0.43

u/ml

0.93

181

Varicose veins

347

3014

0.87

1.86

1.1

0.52

1.13

u/ml

3.13

148

1419

Sequelae of injuries of upper limb

104

803

1.30

1.85

1.1

0.80

1.63

u/ml

1.53

402

Cardiomyopathy (excluding other)

577

0.66

1.85

1.2

1.1

1.60

1.32

u/ml

0.14

302

Short Achilles tendon (acquired)

167

1.69

1.85

1.1

1.0

4.83

2.17

u/ml

0.25

Any mental disorder

1363

6343

1.08

1.85

1.1

1.78

1.89

u/ml

0.19

766

3090

Malignant neoplasm of bladder

100

1.90

1.85

1.1

1.09

0.24

u/ml

0.38

Synovial cyst of popliteal space [Baker]

342

1.47

1.84

1.1

1.0

2.06

1.81

u/ml

0.05

168

Sicca syndrome [Sjögren]

518

1.38

1.84

1.1

0.30

1.37

u/ml

3.09

248

Polyarthrosis

117

824

1.28

1.84

1.1

1.04

1.02

u/ml

0.01

395

KRA_PSY_EATING, excluding more controls

180

1470

1.22

1.84

1.1

2.24

2.50

u/ml

0.14

104

751

Rash and other nonspecific skin eruption

725

1.32

1.84

1.1

2.27

1.50

u/ml

0.39

384

L02BG Aromatase inhibitors

134

1651

0.80

1.84

1.1

1.18

1.11

u/ml

0.06

784

LeFortI or BSSO operation

477

1.40

1.84

1.1

1.96

1.87

u/ml

0.03

237

Chronic apical periodontitis

1261

7609

0.93

1.84

1.1

1.54

1.76

u/ml

0.41

662

3771

Poisoning by drugs, medicaments and biological substances

258

3022

0.85

1.83

1.1

1.50

2.06

u/ml

1.03

152

1563

Testicular hypofunction

286

1.52

1.83

1.0

1.1

2.67

1.95

u/ml

0.13

141

Fracture at wrist and hand level

431

3795

1.13

1.83

1.1

2.76

1.92

u/ml

0.91

242

1990

Other retinal disorders

369

3205

0.87

1.83

1.1

0.69

1.34

u/ml

2.66

182

1624

Other abnormalities of plasma proteins

2.15

1.83

1.1

5.49

0.47

u/ml

—

Fracture of femur

899

0.74

1.83

1.0

1.1

2.23

1.31

u/ml

0.51

490

Corneal degeneration

2.15

1.83

1.1

1.0

0.77

0.30

u/ml

—

Procedures for purposes other than remedying health state

168

1.69

1.82

1.1

1.0

2.29

0.84

u/ml

0.49

Spirochaetal infections, other/unspecified

545

1.36

1.82

1.1

1.07

1.68

u/ml

0.52

287

Trigeminal neuralgia

385

1.44

1.81

1.1

0.14

1.44

u/ml

4.30

191

Injuries to the hip and thigh

396

3117

1.14

1.81

1.1

2.30

1.69

u/ml

0.54

222

1624

Bulimia nervosa (incl. atypical)

556

1.37

1.81

1.2

1.1

0.84

1.91

u/ml

2.01

280

Pterygium

2.07

1.81

1.0

1.1

0.14

1.01

u/ml

—

Atrial fibrillation and flutter

221

1696

0.84

1.81

1.1

2.00

1.44

u/ml

0.33

109

801

Cluster headache, wide,, including avohilmo

547

1.36

1.80

1.1

0.55

1.70

u/ml

3.45

261

Excessive vomiting in pregnancy

130

1038

1.26

1.80

1.1

0.62

1.80

u/ml

3.12

497

Presence of other devices

135

1063

1.25

1.79

1.1

0.24

1.22

u/ml

6.10

525

Skin changes due to chronic exposure to nonionizing radiation

129

928

1.26

1.79

1.1

0.72

0.82

u/ml

0.08

482

Dental caries, including avohilmo

771

3587

1.10

1.79

1.1

1.46

1.76

u/ml

0.54

409

1723

Benign paroxysmal vertigo

212

1778

1.20

1.79

1.1

1.36

1.14

u/ml

0.18

106

870

Use of donepezil

249

0.50

1.78

1.0

1.1

0.08

0.42

u/ml

—

138

Primary hyperparathyroidism

470

1.39

1.78

1.1

0.47

1.27

u/ml

1.56

244

Malignant neoplasm of corpus uteri, including Hilmo

312

0.54

1.77

1.1

1.80

0.96

u/ml

—

159

Chalazion

119

941

1.27

1.77

1.1

1.08

1.65

u/ml

0.62

476

Emotional disorders and disorders of social functioning with onset specific to childhood

151

1205

1.24

1.76

1.1

1.86

2.96

u/ml

0.76

750

Other disorders of male genital organs

305

1.49

1.76

1.0

1.1

0.39

2.89

u/ml

3.28

175

Benign neoplasm: Transverse colon

387

1.43

1.76

1.1

0.17

1.19

u/ml

3.28

204

Alcoholic liver disease

449

0.62

1.76

1.0

1.1

0.13

1.09

u/ml

4.68

226

Graves ophthalmopathy

162

1.69

1.76

1.0

1.1

0.58

1.39

u/ml

0.71

Testicular dysfunction

330

1.47

1.76

1.0

1.1

2.43

2.54

u/ml

0.02

167

Fever of other and unknown origin

662

5199

1.10

1.74

1.1

2.03

2.13

u/ml

0.08

376

2672

Non-Hodgkin lymphoma, all, including Hilmo

508

0.65

1.73

1.0

1.1

6.80

1.35

u/ml

—

265

Excessive earwax

581

4744

1.11

1.73

1.1

1.53

1.82

u/ml

0.31

308

2482

Parkinson's disease

360

0.58

1.72

1.0

1.1

0.43

0.88

u/ml

0.82

188

Collagenous colitis

637

1.33

1.72

1.1

1.19

1.58

u/ml

0.26

322

Nontoxic goitre/thyroid nodule

202

1694

1.20

1.72

1.1

0.75

1.14

u/ml

0.45

102

837

Artrosis, including avohilmo

918

4616

1.09

1.72

1.1

1.23

1.56

u/ml

0.82

446

2233

Contusion of toe(s) with damage to nail

111

1.84

1.71

1.2

1.1

1.92

0.83

u/ml

—

Pediculosis, acariasis and other infestations, including avohilmo

284

2453

1.16

1.71

1.1

1.95

2.41

u/ml

0.35

158

1315

Autonomic disorders

179

1.64

1.71

1.1

0.41

1.88

u/ml

1.99

Cholecystectomy

651

5012

1.10

1.71

1.1

1.03

1.42

u/ml

1.05

317

2393

Extracorporeal dialysis

333

0.57

1.71

1.0

1.1

0.53

1.44

u/ml

2.04

180

Fitting and adjustment of other devices

198

1458

1.20

1.70

1.1

0.40

1.24

u/ml

4.04

103

705

Helminthiases

126

1.77

1.70

1.3

1.1

1.37

1.74

u/ml

0.14

Other ill-defined and unspecified causes of mortality

229

0.48

1.70

1.0

1.1

0.69

1.37

u/ml

—

122

Other disorders of prostate

1.96

1.70

1.1

0.32

2.77

u/ml

—

Poisoning by medicine

233

2730

0.85

1.69

1.1

1.51

2.07

u/ml

0.95

139

1403

Aplastic and other anaemias

212

2292

0.84

1.68

1.1

1.20

1.29

u/ml

0.09

113

1198

Benign neoplasm: Small intestine

126

1.76

1.68

1.4

1.0

0.58

1.40

u/ml

0.48

Dizziness and giddiness

779

5542

1.09

1.68

1.1

1.05

1.69

u/ml

1.97

407

2762

Respiratory insufficiency

133

1.73

1.68

1.0

2.44

0.62

u/ml

0.44

Event of undetermined intent

693

1.31

1.68

1.1

1.88

1.65

u/ml

0.11

352

Presence of other functional implants

282

2234

0.86

1.67

1.1

1.85

1.00

u/ml

0.72

111

1132

Hyperplasia of prostate

180

837

1.21

1.66

1.1

0.52

1.15

u/ml

1.43

430

696

0.71

1.66

1.2

4.48

3.22

u/ml

0.23

493

Inflammation of lacrimal passages (acute and unspecified)

1.91

1.66

1.2

1.1

0.17

1.06

u/ml

—

Pre-eclampsia or eclampsia

209

2466

0.84

1.66

1.1

2.04

1.36

u/ml

0.45

1209

Diseases of pulp and periapical tissues and dental caries

696

3242

1.10

1.66

1.1

1.43

1.78

u/ml

0.64

370

1551

Other bursitis of hip

1.91

1.66

1.1

1.0

0.77

1.57

u/ml

0.50

Delivery, wide proxy

340

2062

0.87

1.66

1.1

1.74

2.23

u/ml

0.65

186

1078

Bacterial pneumoniae

350

2696

1.14

1.65

1.1

1.89

1.53

u/ml

0.38

218

1392

Exposure to other and unspecified inanimate mechanical forces

105

827

1.28

1.65

1.2

1.1

1.37

1.54

u/ml

0.13

443

Diving or jumping into water causing injury other than drowning or submersion

2.46

1.64

1.1

0.95

1.37

u/ml

—

Adhesive capsulitis of shoulder

118

942

1.26

1.64

1.1

0.63

1.28

u/ml

1.21

436

Symptoms and signs involving emotional state

336

1.44

1.63

1.1

1.43

2.19

u/ml

0.58

179

Maternal care for other conditions predominantly related to pregnancy

374

3222

1.14

1.63

1.1

1.50

1.84

u/ml

0.29

177

1562

Cardiomyopathies, Primary/intrinsic

547

0.67

1.62

1.2

1.1

1.60

1.37

u/ml

0.11

290

Major coronary heart disease event

608

4010

0.91

1.61

1.1

1.38

1.57

u/ml

0.25

278

2051

Infections, IBD-co-morbidities

173

1008

1.21

1.61

1.1

0.92

2.12

u/ml

2.13

533

Impacted cerumen

644

1.31

1.61

1.1

2.81

1.40

u/ml

0.51

378

Tooth eruption problems

342

2907

1.14

1.60

1.1

2.94

2.77

u/ml

0.10

199

1686

Certain conditions originating in the perinatal period

228

1730

1.18

1.60

1.1

4.89

3.03

u/ml

0.94

154

1074

Astigmatism

104

821

1.27

1.60

1.1

1.2

1.90

2.22

u/ml

0.13

516

Other specified/unspecified disorders of bone/cartilage

159

1.65

1.60

1.1

1.59

1.80

u/ml

—

Pre-eclampsia

200

2359

0.84

1.60

1.1

2.15

1.38

u/ml

0.50

1158

Cellulitis

241

2068

1.17

1.60

1.1

2.43

1.82

u/ml

0.37

139

1076

Other specified disorders of muscle

167

1.63

1.59

1.0

1.1

2.32

1.79

u/ml

0.13

Other abnormal uterine and vaginal bleeding

214

1303

1.18

1.58

1.1

0.86

1.61

u/ml

1.70

111

663

Bicornuate uterus

1.98

1.57

1.0

1.1

0.16

1.14

u/ml

—

Intestinal malabsorption

355

1.42

1.57

1.1

3.23

1.60

u/ml

0.37

194

Other and unspecified injuries of lower leg

103

815

1.27

1.57

1.1

2.36

1.87

u/ml

0.15

436

Other superficial mycoses, including avohilmo

163

1356

1.21

1.56

1.1

1.99

1.81

u/ml

0.13

689

Chronic mastoiditis

1.86

1.56

1.1

1.0

0.78

0.77

u/ml

—

Sarcoidosis

110

877

1.26

1.56

1.1

2.72

1.40

u/ml

0.37

416

786

0.74

1.56

1.1

1.2

4.06

3.56

u/ml

0.09

553

Hallux rigidus

604

1.31

1.55

1.1

0.77

1.10

u/ml

0.33

302

Cluster headache, strict, including avohilmo

536

1.34

1.55

1.1

0.56

1.73

u/ml

3.40

257

Asymmetry of jaw

177

1.61

1.54

1.1

1.04

2.04

u/ml

0.77

Benign neoplasm: Sigmoid colon

736

1.28

1.54

1.0

1.1

0.76

1.04

u/ml

0.24

370

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

693

0.72

1.54

1.0

1.1

0.92

1.08

u/ml

0.09

358

Hypertensive diseases (excluding secondary)

666

4240

0.91

1.53

1.1

1.47

1.69

u/ml

0.33

355

2074

Contact with heat and hot substances

563

1.32

1.53

1.1

6.34

1.78

u/ml

1.56

315

Unstable angina pectoris

964

0.79

1.53

1.1

0.63

0.89

u/ml

0.47

485

Benign neoplasm of bone and articular cartilage

747

1.28

1.53

1.0

1.1

2.07

1.56

u/ml

0.22

377

Reimbursement for rheumatic diseases

478

5269

0.90

1.53

1.1

1.07

1.78

u/ml

1.98

250

2667

Other diseases of peritoneum

241

1.50

1.52

1.0

1.1

1.44

0.90

u/ml

0.29

121

Traumatic subdural haemorrhage

382

0.63

1.52

1.1

0.54

1.12

u/ml

0.70

203

Other congenital malformations, including avohilmo

211

1801

1.18

1.52

1.1

1.76

2.39

u/ml

0.62

135

1013

Abnormal blood-pressure reading, without diagnosis

299

1.45

1.51

1.1

3.28

1.55

u/ml

0.43

155

Emergency coronary revascularization (for ACS)

594

3942

0.91

1.51

1.1

1.41

1.57

u/ml

0.21

266

2019

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

350

1.41

1.51

1.2

1.1

1.57

2.11

u/ml

0.35

175

Deep bite that required surgery

116

1.75

1.51

1.0

1.1

0.73

1.18

u/ml

—

Other/unspecified enthesopathies, not elsewhere classified

477

1.35

1.51

1.2

1.1

0.68

1.85

u/ml

1.86

227

Viral meningitis

367

1.40

1.51

1.1

1.36

1.97

u/ml

0.46

189

Other injuries of lower limb, level unspecified

1.98

1.50

1.1

3.20

0.61

u/ml

—

Chronic suppurative otitis media, including avohilmo

758

1.27

1.50

1.1

1.14

2.08

u/ml

1.09

433

Other diseases of pleura

246

1844

1.16

1.50

1.1

1.15

1.28

u/ml

0.17

135

950

Cardiac murmurs and other cardiac sounds

127

1024

1.23

1.49

1.1

3.01

2.40

u/ml

0.27

567

Malignant neoplasm of head and neck

269

0.56

1.49

1.1

0.15

1.18

u/ml

—

126

Bursitis of shoulder

139

1.67

1.49

1.1

1.0

0.29

2.50

u/ml

2.15

Congenital malformations of the respiratory system

227

1.52

1.49

1.2

1.66

1.97

u/ml

0.11

157

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

868

5925

0.92

1.49

1.1

0.93

1.53

u/ml

3.30

435

2868

Persons with potential health hazards related to communicable diseases

663

6021

1.09

1.49

1.1

2.32

2.28

u/ml

0.03

337

3248

Mixed specific developmental disorders

619

0.72

1.48

1.1

1.2

2.43

2.76

u/ml

0.11

442

Retention of urine

131

1291

0.82

1.48

1.2

1.1

0.95

1.24

u/ml

0.31

651

Osteopathies and chondropathies

533

4414

1.10

1.48

1.1

1.58

1.71

u/ml

0.12

284

2265

Malignant neoplasm of prostate

566

0.76

1.48

1.0

1.1

0.69

0.87

u/ml

0.24

277

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

132

1.70

1.48

1.1

2.55

2.21

u/ml

0.06

Sequelae of external causes of morbidity and mortality

206

1758

1.17

1.48

1.1

1.83

1.34

u/ml

0.31

133

879

Leiomyoma of uterus

569

3513

0.91

1.48

1.1

1.14

1.29

u/ml

0.19

238

1646

Cerebral cysts

575

1.31

1.48

1.2

1.1

1.49

1.83

u/ml

0.18

299

Congenital malformations of the respiratory system, including avohilmo

252

1.49

1.48

1.2

1.52

1.99

u/ml

0.19

169

Other arrhythmias

729

5000

1.09

1.47

1.1

1.46

1.59

u/ml

0.16

366

2463

Melanoma in situ of trunk

2.24

1.47

1.0

0.10

0.58

u/ml

—

Dislocation, sprain and strain of joint and ligaments of hip

171

1.59

1.46

1.2

1.1

3.77

1.96

u/ml

0.41

Postpartum haemorrhage due to anatomy

195

1662

1.18

1.46

1.1

1.69

1.75

u/ml

0.03

803

Bitten or struck by other mammals

167

1404

1.20

1.45

1.1

2.07

1.80

u/ml

0.15

100

710

Benign neoplasm: Bones of skull and face

2.07

1.45

1.0

5.74

0.78

u/ml

—

Other diseases of blood and blood-forming organs, wide

184

1560

1.18

1.44

1.1

2.39

1.29

u/ml

0.69

104

815

Benign neoplasm: Skin of eyelid, including canthus

789

1.26

1.43

1.1

2.46

1.51

u/ml

0.56

382

Perforation of tympanic membrane

100

799

1.26

1.43

1.1

1.13

1.80

u/ml

0.84

416

Pulmonary artery stenosis

0.00

1.43

0.0

1.2

—

1.02

—

Injuries to the thorax

389

3475

1.12

1.43

1.1

1.75

1.62

u/ml

0.10

204

1754

Rare circulating lymphoid malignancy, including Hilmo

213

0.51

1.42

1.0

1.2

0.24

1.45

u/ml

—

144

Tic and related disorders

271

1.47

1.42

1.1

1.2

2.81

2.15

u/ml

0.19

179

Pulmonary embolism

169

1423

1.19

1.42

1.1

0.77

1.17

u/ml

0.79

693

Bruxism

205

1.53

1.42

1.1

0.75

1.36

u/ml

0.61

Eustachian salpingitis and obstruction

131

1080

1.22

1.42

1.1

3.16

2.02

u/ml

0.32

552

Postpartum hemorraghe, parous women as controls

425

3194

1.12

1.42

1.1

1.54

1.74

u/ml

0.24

192

1527

Dermatitis herpetiformis

1.87

1.41

1.0

3.72

0.85

u/ml

—

Other peripheral vertigo

457

1.34

1.41

1.1

0.94

1.13

u/ml

0.22

233

Pulmonary heart disease

169

1425

1.19

1.41

1.1

0.77

1.16

u/ml

0.78

695

Coronary revascularization (ANGIO or CABG)

580

3860

0.91

1.40

1.1

1.43

1.60

u/ml

0.20

261

1973

Degenerative macular diseases

329

1.40

1.0

1.1

1.38

1.57

u/ml

0.06

175

Ehlers-Danlos syndrome, including avohilmo

166

1.60

1.40

1.0

1.1

1.63

2.07

u/ml

0.17

Disorders of iron metabolism

1.79

1.40

1.1

5.80

1.77

u/ml

—

Biomechanical lesions, not elsewhere classified

271

1.45

1.40

1.2

1.1

0.94

2.03

u/ml

0.99

131

Chronic suppurative otitis media

580

1.30

1.39

1.1

1.03

2.20

u/ml

1.44

322

Tongue abnormality

313

1.41

1.39

1.1

1.06

1.50

u/ml

0.29

162

Other viral diseases, not elsewhere classified

275

2405

1.14

1.39

1.1

2.28

2.64

u/ml

0.19

139

1356

Muscle strain

280

1.44

1.39

1.1

0.50

2.28

u/ml

2.96

144

Other and unspecified mononeuropathies of lower limb

150

1.61

1.38

1.0

0.42

1.43

u/ml

1.02

Melanocytic naevi of other and unspecified parts of face

511

1.32

1.38

1.1

1.59

1.72

u/ml

0.04

259

Viral infections of the central nervous system, including avohilmo

687

1.27

1.38

1.1

1.00

1.75

u/ml

1.07

352

Need for other prophylactic measures

494

1.32

1.38

1.1

0.43

1.74

u/ml

2.91

292

Cardiac arrest

223

0.57

1.38

1.0

1.1

2.21

1.72

u/ml

—

112

Malignant neoplasm of breast, HER-negative

1062

0.79

1.37

1.1

0.93

0.97

u/ml

0.03

499

Other disorders of Eustachian tube

223

1.49

1.37

1.2

1.1

1.33

2.00

u/ml

0.30

113

Dystonia

408

1.36

1.37

1.1

1.40

1.66

u/ml

0.15

209

Hypertrophy of tongue papillae

1.85

1.37

1.1

1.0

0.22

1.72

u/ml

—

Ptosis of eyelid

468

1.33

1.37

1.1

0.84

1.43

u/ml

0.77

236

Other abnormal auditory perceptions

1.78

1.36

1.4

1.1

3.40

0.79

u/ml

—

Abnormal involuntary movements

122

1002

1.22

1.36

1.1

2.63

1.68

u/ml

0.62

515

Fall on same level

1588

8005

1.06

1.36

1.1

1.75

2.06

u/ml

0.71

869

4064

Struck by thrown, projected or falling objec

530

1.31

1.36

1.2

1.1

1.79

1.81

u/ml

0.01

284

Cluster headache, wide

349

1.39

1.36

1.0

1.1

0.52

1.77

u/ml

2.93

169

Benign neoplasm: Adrenal gland

357

1.38

1.36

1.0

1.1

0.86

1.08

u/ml

0.21

178

Contact with other hot fluids

341

1.39

1.35

1.1

8.48

2.17

u/ml

1.41

198

Open wound of lower leg

157

1323

1.19

1.35

1.1

3.17

1.89

u/ml

0.75

722

Shoulder region

105

1.74

1.34

1.1

1.0

0.27

1.33

u/ml

1.24

Parkinson's disease, excluding more controls

308

0.63

1.34

1.0

0.43

0.66

u/ml

0.38

164

Dilated cardiomyopathy

466

0.68

1.34

1.2

1.1

1.86

1.33

u/ml

0.25

247

Toxic effects of substances chiefly nonmedicinal as to source

140

1169

1.20

1.34

1.1

1.10

1.76

u/ml

1.01

625

Other specified/unspecified arthritis

268

2355

1.14

1.33

1.1

1.04

1.60

u/ml

1.14

142

1196

Peripheral arterial reconstruction

370

0.65

1.33

1.2

1.0

0.27

1.08

u/ml

1.72

192

Parkinson's disease, strict definition

309

0.61

1.33

1.1

0.47

0.93

u/ml

0.76

167

Malignant neoplasm of ovary, including Hilmo

296

0.61

1.32

1.0

1.1

1.20

1.30

u/ml

—

141

Abnormal results of function studies

718

1.26

1.32

1.1

0.55

1.76

u/ml

3.08

372

Non-ischemic cardiomyopathy

103

1006

0.81

1.32

1.1

0.30

1.02

u/ml

2.83

535

Other benign neoplasms of uterus

144

1.60

1.32

1.1

1.0

1.21

0.61

u/ml

—

Scabies, including avohilmo

253

2218

1.15

1.32

1.1

1.90

2.46

u/ml

0.41

139

1193

Other female pelvic inflammatory diseases

151

1271

1.19

1.32

1.1

1.13

1.36

u/ml

0.23

601

Palmar fascial fibromatosis [Dupuytren]

445

1.33

1.31

1.0

1.1

1.26

1.44

u/ml

0.08

217

Anomalies of pupillary function

201

1.51

1.31

1.2

1.1

3.08

1.84

u/ml

0.18

109

Pure hypercholesterolaemia

527

3667

0.91

1.31

1.1

1.17

1.28

u/ml

0.15

315

1738

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

311

2763

1.13

1.31

1.1

1.06

1.83

u/ml

1.88

158

1415

Persistent mood disorders

198

1706

1.16

1.30

1.1

1.93

1.64

u/ml

0.24

114

817

Enlarged lymph nodes

160

1355

1.18

1.30

1.1

2.55

1.84

u/ml

0.47

692

Angina pectoris

236

1795

0.87

1.30

1.1

1.18

0.89

u/ml

0.38

108

884

Other complications of labour and delivery, not elsewhere classified

201

2057

0.86

1.30

1.1

1.91

2.02

u/ml

0.07

1003

Glomerulonephritis

727

0.75

1.30

1.0

1.1

0.86

1.64

u/ml

0.77

398

Malignant neoplasm of pancreas, including Hilmo

232

0.56

1.30

1.0

1.1

1.35

1.10

u/ml

—

116

Benign neoplasm of other and unspecified endocrine glands

104

846

1.23

1.29

1.0

1.1

0.69

1.34

u/ml

1.88

426

Diplopia

104

846

1.23

1.29

1.1

0.75

1.62

u/ml

1.10

419

Pneumonia due to Streptococcus pneumoniae

251

1.44

1.29

1.1

2.56

1.76

u/ml

0.25

127

Bilateral sagittal split ramus osteotomy operation

396

1.35

1.29

1.1

2.28

2.04

u/ml

0.09

192

Pregnancy, childbirth and the puerperium

308

1813

0.88

1.29

1.1

2.21

2.55

u/ml

0.26

167

958

Keratoconus

202

1.50

1.28

1.1

8.47

1.85

u/ml

1.32

105

Percutaneous Coronary Intervention

582

3857

0.92

1.28

1.1

1.43

1.60

u/ml

0.21

262

1972

Acute otitis externa, noninfective

1.74

1.28

1.2

1.0

0.75

1.35

u/ml

—

Diabetic nephropathy, excluding more controls

583

0.75

1.28

1.1

2.79

1.14

u/ml

0.68

312

Neuromuscular dysfunction of bladder

500

1.30

1.28

1.2

1.1

1.17

1.45

u/ml

0.14

257

Pleural plaque with presence of asbestos

1.79

1.27

1.1

0.36

0.41

u/ml

—

Residual foreign body in soft tissue

440

1.33

1.27

1.1

2.73

1.88

u/ml

0.21

218

Early lumbar disc prolapse, operated

153

1296

1.19

1.26

1.1

1.65

1.66

u/ml

0.00

600

Ischaemic heart disease, wide definition

444

3013

0.91

1.26

1.1

1.25

1.21

u/ml

0.05

205

1442

Malignant neoplasm of corpus uteri

267

0.60

1.26

1.1

1.80

0.97

u/ml

—

136

Sacroiliitis, not elsewhere classified

555

1.29

1.26

1.0

1.1

2.34

1.54

u/ml

0.28

274

Car occupant injured in other and unspecified transport accidents

251

2208

1.14

1.25

1.1

1.56

1.89

u/ml

0.39

110

1130

Transient ischemic attack

205

1882

0.87

1.25

1.1

1.51

1.00

u/ml

0.44

124

921

Burn and corrosion confined to eye and adnexa

195

1.50

1.25

1.1

0.91

1.56

u/ml

0.39

100

Inflammatory disease of cervix uteri

337

1.37

1.25

1.2

1.1

0.77

0.92

u/ml

0.13

154

Misadventures to patients during surgical and medical care

116

958

1.21

1.25

1.1

0.74

1.40

u/ml

1.19

479

Chronic iridocyclitis

387

0.67

1.25

1.0

1.1

0.74

1.88

u/ml

1.48

209

Exposure to other and unspecified animate mechanical forces

407

1.34

1.25

1.1

1.53

1.92

u/ml

0.17

224

Other infective otitis externa

450

1.32

1.24

1.1

1.83

1.55

u/ml

0.12

232

Tic and related disorders

280

1.42

1.24

1.1

1.2

2.81

2.69

u/ml

0.03

192

Glomerular diseases

106

1288

0.82

1.24

1.1

2.73

1.44

u/ml

0.51

682

Hypertension, essential

788

4789

0.93

1.24

1.1

1.42

1.44

u/ml

0.04

418

2248

Non-follicular lymphoma

339

0.65

1.24

1.0

1.1

10.79

1.52

u/ml

—

192

Other bursitis of knee

1.79

1.24

1.1

1.0

0.23

2.12

u/ml

—

Benign neoplasm: Rectum, anus and anal canal

805

1.23

1.24

1.1

0.94

1.04

u/ml

0.10

404

Emotional disorders starting during childhood or adolescence

139

1162

1.20

1.23

1.2

1.1

1.96

3.10

u/ml

0.75

722

Mixed conductive and sensorineural hearing loss

547

1.28

1.23

1.1

1.45

1.37

u/ml

0.03

295

Other acquired deformities of musculoskeletal system and connective tissue

296

1.39

1.23

1.1

2.84

1.31

u/ml

0.36

146

Other disorders of fluid, electrolyte and acid-base balance

142

1580

0.84

1.22

1.2

1.1

0.83

1.23

u/ml

0.60

792

Ulcerative colitis (strict definition, require KELA)

156

1827

0.85

1.22

1.1

1.25

1.81

u/ml

0.65

946

Other congenital malformations of skin

461

1.31

1.22

1.1

1.06

2.63

u/ml

2.03

268

Other endocrine disorders

116

923

1.21

1.1

1.2

2.79

2.92

u/ml

0.05

621

Speech and linguistic disorders, excluding more controls

173

1395

1.17

1.21

1.2

1.1

3.34

2.72

u/ml

0.24

122

841

Nerve, nerve root and plexus disorders

1190

6735

1.06

1.21

1.1

1.38

1.62

u/ml

0.46

576

3291

Additional codes for the location of defect, injury or illness

444

1.31

1.20

1.0

1.1

1.29

1.83

u/ml

0.29

240

Obstructed labour due to maternal pelvic abnormality

131

1100

1.19

1.20

1.0

1.1

1.00

1.08

u/ml

0.04

519

Non-small cell lung cancer

211

0.56

1.20

1.0

1.1

1.31

0.86

u/ml

—

102

Supernumerary ureter

0.00

1.19

0.0

1.1

—

3.92

—

Other and unspecified epidermal thickening

189

1.49

1.19

1.1

1.32

1.21

u/ml

0.08

102

Supervision of high-risk pregnancy

299

2015

0.89

1.19

1.1

1.87

2.12

u/ml

0.18

137

969

Juvenile osteochondrosis

428

1.32

1.19

1.1

3.59

2.07

u/ml

0.21

228

Peripheral artery operations in Hilmo

347

0.66

1.18

1.2

1.1

0.30

0.98

u/ml

1.92

180

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

285

0.62

1.18

1.0

1.1

3.20

1.65

u/ml

—

139

Hyperparathyroidism

703

1.24

1.18

1.1

0.40

1.07

u/ml

2.03

346

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

166

1.54

1.18

1.1

3.69

1.88

u/ml

0.26

109

Congenital malformations of the nervous system

380

0.68

1.18

1.1

1.2

5.16

2.50

u/ml

0.27

242

Syncope and collapse

403

3049

1.10

1.18

1.1

2.13

1.92

u/ml

0.18

208

1561

Bullous disorders

256

1.41

1.18

1.1

2.54

1.53

u/ml

0.41

135

Erythema nodosum

198

1.48

1.17

1.1

0.22

1.96

u/ml

2.41

100

Benign neoplasm: Scapula and long bones of upper limb

1.83

1.16

1.1

0.77

1.84

u/ml

—

Explicit bacterial Sepsis

691

0.76

1.16

1.0

1.1

1.80

1.73

u/ml

0.03

376

Myocarditis

368

1.34

1.16

1.2

1.1

0.98

1.31

u/ml

0.31

183

Ulcerative colitis (strict definition, all Crohn cases excluded)

130

1537

0.84

1.16

1.1

1.41

1.80

u/ml

0.33

782

Chromosomal abnormalities, not elsewhere classified

458

0.71

1.15

1.1

1.2

4.42

2.29

u/ml

0.44

314

Lesion of plantar nerve

291

1.38

1.15

1.1

0.71

1.20

u/ml

0.45

146

Other sexually transmitted chlamydial diseases, including avohilmo

220

1934

1.14

1.15

1.1

1.41

2.53

u/ml

1.88

123

1044

Single delivery by caesarean section

301

1920

0.89

1.15

1.1

2.36

1.89

u/ml

0.30

141

991

Campylobacter enteritis

191

1.48

1.14

1.0

1.1

2.03

1.80

u/ml

0.09

Embedded teeth, including avohilmo

176

1524

1.16

1.14

1.1

1.73

2.18

u/ml

0.26

100

839

Chronic myeloproliferative disease

0.00

1.14

0.0

1.1

—

1.16

—

Superficial injury of shoulder and upper arm

128

1079

1.19

1.14

1.1

1.94

1.56

u/ml

0.26

560

Benign intracranial hypertension

151

1.55

1.14

1.1

1.52

1.38

u/ml

0.06

Vascular disorders of the intestines

150

1.54

1.14

1.1

1.14

1.22

u/ml

0.03

Diffuse brain injury

271

0.62

1.14

1.2

1.1

1.51

1.60

u/ml

—

140

Ehlers-Danlos syndrome

135

1.59

1.14

1.0

1.1

1.72

2.17

u/ml

0.15

Intracranial injury

669

5790

1.08

1.14

1.1

1.85

2.03

u/ml

0.20

376

3059

Wet age-related macular degeneration

224

1.42

1.13

1.0

1.1

0.04

0.29

u/ml

2.53

127

Finngen Rheumatological endpoints

1182

7091

0.94

1.13

1.1

1.17

1.93

u/ml

3.66

615

3556

Burn and corrosion of wrist and hand

441

1.30

1.12

1.1

4.71

1.96

u/ml

0.90

248

Infections of genitourinary tract in pregnancy

1063

0.81

1.12

1.1

3.73

1.86

u/ml

0.63

534

Arthropathic psoriasis

865

0.79

1.11

1.1

1.26

1.31

u/ml

0.02

405

Benign neoplasm: Rectum

708

1.23

1.11

1.1

0.99

1.12

u/ml

0.13

366

Viral agents as the cause of diseases classified to other chapters, including avohilmo

243

1.41

1.11

1.1

2.57

2.14

u/ml

0.12

136

Other disorders of breast and lactation associated with childbirth

252

1.41

1.10

1.1

1.03

1.38

u/ml

0.21

124

Heterophoria

114

955

1.20

1.10

1.1

1.35

1.78

u/ml

0.37

539

Parkinson's disease, strict definition, excluding more controls

274

0.65

1.10

1.1

1.0

0.47

0.63

u/ml

0.23

146

Hodgkin lymphoma, hilmo

207

0.58

1.10

1.3

1.1

1.41

1.87

u/ml

—

117

Alcohol abuse, main dg

128

1508

0.85

1.10

1.1

2.62

1.81

u/ml

0.43

770

Mumps

168

1.50

1.10

1.1

2.69

1.65

u/ml

0.16

Deep endometriosis

107

891

1.21

1.10

1.1

0.65

1.21

u/ml

1.29

444

Other hammer toe(s) (acquired)

578

1.24

1.10

1.1

0.64

1.00

u/ml

0.66

288

Postdysenteric arthropathy

1.85

1.10

1.2

1.0

0.73

2.47

u/ml

—

Superficial injury of forearm

138

1176

1.18

1.10

1.1

1.79

2.00

u/ml

0.14

632

Burns and corrosions of multiple and unspecified body regions

194

0.56

1.10

1.0

1.1

4.68

1.56

u/ml

—

114

Non-invasive ventilation

286

2208

1.12

1.10

1.1

2.22

1.71

u/ml

0.27

161

1052

Malignant neoplasm of breast, ER-negative, including Hilmo

108

1208

0.83

1.10

1.1

0.79

1.02

u/ml

0.25

570

Viral infections of the central nervous system

611

1.25

1.09

1.1

1.09

1.80

u/ml

0.88

314

Benign neoplasm: Other and unspecified parts of mouth

160

1.51

1.09

1.1

8.46

1.89

u/ml

0.62

Ménière disease

433

1.30

1.09

1.1

0.81

1.21

u/ml

0.30

221

Fracture of neck

256

0.62

1.09

1.1

0.62

1.45

u/ml

—

136

Benign neoplasm: Cerebral meninges

407

1.31

1.09

1.1

0.91

0.90

u/ml

0.01

197

Diseases of the digestive system

370

3334

1.10

1.09

1.1

2.73

1.70

u/ml

0.66

210

1772

Malignant neoplasm of prostate, including Hilmo

597

0.81

1.09

1.0

1.1

0.67

0.85

u/ml

0.25

292

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

460

1.29

1.09

1.1

2.89

1.23

u/ml

0.37

233

Monoarthritis, not elsewhere classified

287

1.37

1.07

1.1

1.86

1.58

u/ml

0.09

147

Whooping cough, including avohilmo

237

1.41

1.06

1.2

1.1

1.23

1.80

u/ml

0.39

129

Other salmonella infections, including avohilmo

322

1.34

1.06

1.1

1.14

1.58

u/ml

0.34

169

Acne vulgaris

184

1607

1.15

1.06

1.2

1.1

2.63

2.64

u/ml

0.01

120

891

Other specified/unspecified hearing loss

409

1.30

1.06

1.2

1.1

1.21

1.52

u/ml

0.16

223

Use of memantine

301

0.69

1.05

1.0

1.1

0.26

0.35

u/ml

0.24

173

Use of other anti-dementia drugs

301

0.69

1.05

1.0

1.1

0.26

0.35

u/ml

0.24

173

Other diseases of arteries and capillaries

489

1.27

1.05

1.0

1.1

3.02

1.40

u/ml

0.30

252

All pneumoniae

1318

8135

1.05

1.1

2.00

1.94

u/ml

0.09

763

4088

Ovarian hyperstimulation (induction)

272

1.38

1.05

1.0

1.1

2.11

1.52

u/ml

0.23

123

Injury of muscle and tendon at ankle and foot level

212

1.43

1.05

1.1

2.10

2.13

u/ml

0.01

104

Presbyopia

579

1.25

1.04

1.1

0.63

1.41

u/ml

1.17

260

Valvular operations

646

0.77

1.04

1.0

1.1

0.80

1.59

u/ml

1.16

354

Septal defects

1020

0.82

1.04

1.1

1.2

3.35

2.85

u/ml

0.19

664

Ulcer of lower limb, not elsewhere classified

533

0.75

1.04

1.2

1.1

0.80

1.35

u/ml

0.53

278

Caught, crushed, jammed or pinched in or between objects

571

1.25

1.04

1.2

1.1

0.86

1.79

u/ml

1.81

304

Graves ophthalmopathy, strict

146

1.52

1.04

1.0

0.66

1.32

u/ml

0.45

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

527

3592

0.92

1.04

1.1

0.91

1.52

u/ml

2.35

263

1694

Nontoxic multinodular goitre

115

970

1.19

1.04

1.0

1.1

0.58

1.26

u/ml

1.43

467

Localized skin eruption due to drugs and medicaments

1.76

1.04

1.0

1.1

0.91

0.85

u/ml

—

Hernia of abdominal wall, postoperative

145

1238

1.17

1.03

1.1

1.46

1.20

u/ml

0.19

611

Other appendicitis

652

1.23

1.03

1.1

3.08

1.56

u/ml

0.73

324

Disorder of lipoprotein metabolism, unspecified

437

1.28

1.03

1.0

1.1

0.87

0.90

u/ml

0.02

224

Other benign neoplasms of skin

287

2582

1.11

1.03

1.1

1.45

1.30

u/ml

0.18

145

1288

Hypertrophic disorders of skin

644

1.23

1.03

1.1

1.48

2.04

u/ml

0.50

328

Convergent concomitant strabismus

732

0.79

1.02

1.1

4.08

1.69

u/ml

0.63

400

Abnormal findings on diagnostic imaging of other body structures

106

889

1.20

1.02

1.1

1.42

1.35

u/ml

0.04

440

Plantar fascial fibromatosis

716

1.22

1.02

1.1

1.56

1.64

u/ml

0.03

328

Problems related to lifestyle

1117

0.83

1.02

1.1

2.87

1.89

u/ml

0.53

554

Hirsprung

0.00

1.02

0.0

1.1

—

1.02

—

Cluster headache, strict

342

1.32

1.02

1.0

1.1

0.54

1.80

u/ml

2.86

166

Benign neoplasm of mouth and pharynx

644

1.23

1.02

1.1

3.62

1.47

u/ml

0.68

316

Non-small cell lung cancer, including Hilmo

358

0.71

1.01

1.1

0.58

1.11

u/ml

0.44

181

Use of levodopa decarboxylase inhibitor

299

0.67

1.01

1.0

1.1

0.30

0.95

u/ml

—

161

Infections of breast associated with childbirth

493

1.27

1.01

1.1

1.95

1.39

u/ml

0.12

236

Atrial fibrillation and flutter with reimbursement

139

1020

0.86

1.01

1.1

1.37

1.00

u/ml

0.30

489

Noonan syndrome

0.00

1.01

0.0

1.1

—

0.51

—

Other specified and unspecified disorders of eye and adnexa

239

1.39

1.01

1.1

2.15

1.74

u/ml

0.12

115

Pneumonias (Asthma/COPD co-morbidities)

1306

8113

1.05

1.01

1.1

1.94

1.95

u/ml

0.02

758

4079

Background retinopathy and retinal vascular changes

1.63

1.00

1.0

1.1

0.19

1.82

u/ml

—

Impacted maxillary canine

190

1.46

1.00

1.0

1.1

4.55

2.74

u/ml

0.37

119

Other deformities of toe(s)

172

1.46

1.00

1.0

1.1

0.70

1.73

u/ml

0.64

Myositis

123

1.55

1.00

1.0

0.23

2.46

u/ml

1.87

Streptococcal septicaemia

517

0.75

1.00

1.0

1.1

1.58

1.79

u/ml

0.07

295

SLE, strict definition

249

0.64

0.99

1.1

0.76

1.15

u/ml

—

128

SLE, ICD10

249

0.64

0.99

1.1

0.76

1.15

u/ml

—

128

Spontaneous abortion

622

3879

1.08

0.99

1.1

1.35

1.65

u/ml

0.55

279

1878

Other diseases of gallbladder

189

1.43

0.99

1.0

1.1

2.88

1.73

u/ml

—

5-aminosalicylic acid

229

2041

1.12

0.99

1.1

1.62

1.68

u/ml

0.05

116

974

Retinal detachments and breaks

195

1720

1.14

0.99

1.1

1.15

u/ml

0.01

845

Polyarthritis, unspecified

223

1.40

0.99

1.1

1.65

2.17

u/ml

0.14

120

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.99

0.0

1.1

—

1.00

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

187

0.58

0.99

1.1

0.29

2.25

u/ml

—

108

Fracture of shoulder and upper arm

270

2993

0.90

0.99

1.1

1.35

2.07

u/ml

1.35

140

1632

Superficial injury of ankle and foot

199

1760

1.13

0.98

1.1

2.87

2.34

u/ml

0.28

114

960

Blindness or visual impairment, binocular

0.00

0.98

0.0

1.0

—

0.24

—

Delayed milestone in childhood

598

0.78

0.98

1.1

1.2

4.46

3.40

u/ml

0.27

457

Hypertrophy of bone

0.00

0.98

0.0

1.1

—

0.73

—

Other or ill-defined heart diseases

353

1.31

0.97

1.1

1.99

1.98

u/ml

0.00

183

Alopecia areata

284

1.35

0.97

1.1

2.49

2.06

u/ml

0.13

150

Lupus nephritis

0.00

0.97

0.0

1.0

—

0.34

—

Major anomalies of jaw size

267

1.36

0.97

1.3

1.1

0.76

1.93

u/ml

1.58

148

Aphakia

1.95

0.97

1.3

1.1

0.33

1.50

u/ml

—

Other diseases of blood and blood-forming organs

371

1.30

0.97

1.0

1.1

1.19

1.59

u/ml

0.17

186

Other disorders of bladder

513

1.25

0.97

1.1

1.18

1.40

u/ml

0.12

265

Other specified/unspecified spondylopathies

1.75

0.96

1.0

0.26

1.11

u/ml

—

Mumps, including avohilmo

174

1.45

0.96

1.1

2.69

1.59

u/ml

0.17

Acquired absence of limb

0.00

0.95

0.0

1.0

—

0.41

—

Infectious mononucleosis

167

1465

1.15

0.95

1.1

1.15

2.21

u/ml

2.51

100

787

Infectious mononucleosis, including avohilmo

167

1465

1.15

0.95

1.1

1.15

2.21

u/ml

2.51

100

787

Congenital malformations of cardiac septa

1061

0.83

0.95

1.1

1.2

3.13

2.89

u/ml

0.09

687

Burns and corrosions confined to eye and internal organs

225

1.39

0.95

1.1

0.80

1.43

u/ml

0.46

119

Personal history of other diseases and conditions

217

1926

1.13

0.95

1.1

3.63

2.45

u/ml

0.48

112

1111

Intermittent heterotropia

930

0.82

0.95

1.1

1.2

3.77

2.71

u/ml

0.38

585

Dislocation, sprain and strain of joints and ligaments of thorax

268

1.35

0.95

1.1

0.50

1.87

u/ml

2.10

139

Personality disorders, excluding more controls

366

3345

1.09

0.94

1.1

1.30

1.95

u/ml

1.49

224

1598

Dialysis

293

0.68

0.94

1.0

1.1

0.52

1.73

u/ml

2.19

174

Other and unspecified diseases of blood and blood-forming organs

125

1.53

0.94

1.1

1.0

0.10

1.82

u/ml

1.37

Diabetic maculopathy, excluding more controls

812

0.81

0.94

1.1

1.02

1.81

u/ml

0.86

415

Pneumonia, organism unspecified

1111

7235

1.05

0.94

1.1

1.96

1.85

u/ml

0.15

641

3651

Single delivery by forceps and vacuum extractor

267

1766

0.90

0.94

1.1

1.26

1.86

u/ml

0.90

124

922

Overexertion and strenuous or repetitive movements

103

871

1.19

0.93

1.1

1.26

1.49

u/ml

0.20

433

Ventral hernia

164

1437

1.14

0.93

1.1

1.07

1.30

u/ml

0.22

710

Primary open-angle glaucoma

100

810

1.19

0.93

1.0

1.1

0.49

0.76

u/ml

0.51

428

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

156

1781

0.87

0.93

1.1

1.25

1.83

u/ml

0.69

924

Foreign body in alimentary tract

427

1.27

0.93

1.1

0.78

2.02

u/ml

1.65

246

Other necrotizing vasculopathies (FG)

233

0.64

0.93

1.0

1.1

0.47

1.20

u/ml

—

124

Other/unspecified rheumatoid arthritis

522

0.76

0.93

1.2

1.1

0.70

1.42

u/ml

0.94

256

Malignant neoplasm of urinary organs, including Hilmo

374

0.72

0.93

1.1

1.22

1.03

u/ml

0.07

194

Disorders of parathyroid gland

106

888

1.18

0.93

1.1

1.44

1.20

u/ml

0.13

443

Other and/or unspecified nontoxic goitre

436

1.27

0.92

1.0

1.1

0.37

1.28

u/ml

1.55

210

Diseases of liver

276

2497

1.11

0.92

1.1

1.52

1.40

u/ml

0.07

148

1245

Special screening examination for other diseases and disorders

116

991

1.17

0.92

1.1

3.61

2.36

u/ml

0.51

449

Other and unspecified iron deficiency

292

2644

1.10

0.92

1.1

2.00

1.55

u/ml

0.35

167

1372

Other retinal artery occlusion

1.83

0.92

1.0

1.1

0.63

0.91

u/ml

—

Pilonidal cyst

1114

0.84

0.92

1.1

1.01

1.92

u/ml

1.40

548

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

171

1938

0.88

0.92

1.1

1.56

1.81

u/ml

0.18

1003

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Horse dander IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS